BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 956797 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h1-10,12,14,17H,11,13,15-16H2,(H2,27,29)(H,28,33) BKOMRHGWSXFZSH-UHFFFAOYSA-N 463332 3-Amino-1-[(4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [2-(3-chloro-phenoxy)-ethyl]-amide::US10781181, Example 1 Plasma kallikrein Human 2.90 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463332&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132043552 441573178 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956798 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h1-10,12,14,17H,11,13,15-16H2,(H2,27,29)(H,28,33) BKOMRHGWSXFZSH-UHFFFAOYSA-N 463332 3-Amino-1-[(4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [2-(3-chloro-phenoxy)-ethyl]-amide::US10781181, Example 1 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463332&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132043552 441573178 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956799 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC(=O)Nc1cccc(Cl)c1 InChI=1S/C25H23ClN6O3/c26-19-4-3-5-20(12-19)29-22(33)13-28-25(35)21-16-32(30-24(21)27)15-18-9-7-17(8-10-18)14-31-11-2-1-6-23(31)34/h1-12,16H,13-15H2,(H2,27,30)(H,28,35)(H,29,33) PDHPGDWMHDVKPX-UHFFFAOYSA-N 463333 3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [(3-chloro-phenylcarbamoyl)-methyl]-amide]::US10781181, Example 2 Plasma kallikrein Human 60.2 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463333&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132043553 441573179 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956800 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC(=O)Nc1cccc(Cl)c1 InChI=1S/C25H23ClN6O3/c26-19-4-3-5-20(12-19)29-22(33)13-28-25(35)21-16-32(30-24(21)27)15-18-9-7-17(8-10-18)14-31-11-2-1-6-23(31)34/h1-12,16H,13-15H2,(H2,27,30)(H,28,35)(H,29,33) PDHPGDWMHDVKPX-UHFFFAOYSA-N 463333 3-Amino-1-[4-(2-oxo-2H-pyridin-1-ylmethyl)-benzyl]-1H-pyrazole-4-carboxylic acid [(3-chloro-phenylcarbamoyl)-methyl]-amide]::US10781181, Example 2 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463333&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132043553 441573179 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956801 C[C@@H](CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)Oc1cccc(Cl)c1 InChI=1S/C26H26ClN5O3/c1-18(35-22-6-4-5-21(27)13-22)14-29-26(34)23-17-32(30-25(23)28)16-20-10-8-19(9-11-20)15-31-12-3-2-7-24(31)33/h2-13,17-18H,14-16H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1 ILFFTOFUUCFIFF-SFHVURJKSA-N 463334 3-Amino-N-[(2S)-2-(3-chlorophenoxy)propyl]-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-pyrazole-4-carboxamide::US10781181, Example 115 Plasma kallikrein Human 5.60 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463334&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364589 441573180 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956802 C[C@@H](CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)Oc1cccc(Cl)c1 InChI=1S/C26H26ClN5O3/c1-18(35-22-6-4-5-21(27)13-22)14-29-26(34)23-17-32(30-25(23)28)16-20-10-8-19(9-11-20)15-31-12-3-2-7-24(31)33/h2-13,17-18H,14-16H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1 ILFFTOFUUCFIFF-SFHVURJKSA-N 463334 3-Amino-N-[(2S)-2-(3-chlorophenoxy)propyl]-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-pyrazole-4-carboxamide::US10781181, Example 115 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463334&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364589 441573180 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956803 CNc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H26ClN5O3/c1-28-25-23(26(34)29-12-14-35-22-6-4-5-21(27)15-22)18-32(30-25)17-20-10-8-19(9-11-20)16-31-13-3-2-7-24(31)33/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,30)(H,29,34) LNZQMEQPMVGJKW-UHFFFAOYSA-N 463335 N-[2-(3-Chlorophenoxy)ethyl]-3-(methylamino)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10781181, Example 37 Plasma kallikrein Human 18.5 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463335&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364636 441573181 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956804 CNc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H26ClN5O3/c1-28-25-23(26(34)29-12-14-35-22-6-4-5-21(27)15-22)18-32(30-25)17-20-10-8-19(9-11-20)16-31-13-3-2-7-24(31)33/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,30)(H,29,34) LNZQMEQPMVGJKW-UHFFFAOYSA-N 463335 N-[2-(3-Chlorophenoxy)ethyl]-3-(methylamino)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide::US10781181, Example 37 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463335&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364636 441573181 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956805 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC(=O)Nc1ccccc1Cl InChI=1S/C25H23ClN6O3/c26-20-5-1-2-6-21(20)29-22(33)13-28-25(35)19-16-32(30-24(19)27)15-18-10-8-17(9-11-18)14-31-12-4-3-7-23(31)34/h1-12,16H,13-15H2,(H2,27,30)(H,28,35)(H,29,33) HYDFMOJNDSHUST-UHFFFAOYSA-N 463336 2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 3 Plasma kallikrein Human 5530 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463336&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017352 441573182 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956806 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCC(=O)Nc1ccccc1Cl InChI=1S/C25H23ClN6O3/c26-20-5-1-2-6-21(20)29-22(33)13-28-25(35)19-16-32(30-24(19)27)15-18-10-8-17(9-11-18)14-31-12-4-3-7-23(31)34/h1-12,16H,13-15H2,(H2,27,30)(H,28,35)(H,29,33) HYDFMOJNDSHUST-UHFFFAOYSA-N 463336 2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 3 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463336&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017352 441573182 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956807 Cc1ccc(NC(=O)CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)cc1 InChI=1S/C26H26N6O3/c1-18-5-11-21(12-6-18)29-23(33)14-28-26(35)22-17-32(30-25(22)27)16-20-9-7-19(8-10-20)15-31-13-3-2-4-24(31)34/h2-13,17H,14-16H2,1H3,(H2,27,30)(H,28,35)(H,29,33) IKOCGZFEXKVBPW-UHFFFAOYSA-N 463337 2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 4 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463337&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 155921789 441573183 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956808 Cc1ccc(NC(=O)CNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)cc1 InChI=1S/C26H26N6O3/c1-18-5-11-21(12-6-18)29-23(33)14-28-26(35)22-17-32(30-25(22)27)16-20-9-7-19(8-10-20)15-31-13-3-2-4-24(31)34/h2-13,17H,14-16H2,1H3,(H2,27,30)(H,28,35)(H,29,33) IKOCGZFEXKVBPW-UHFFFAOYSA-N 463337 2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 4 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463337&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 155921789 441573183 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956809 Clc1cccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1 InChI=1S/C28H27ClN4O3/c29-23-4-3-5-24(16-23)36-15-13-30-28(35)25-19-33(31-27(25)22-11-12-22)18-21-9-7-20(8-10-21)17-32-14-2-1-6-26(32)34/h1-10,14,16,19,22H,11-13,15,17-18H2,(H,30,35) IADVHCUBEXJOLV-UHFFFAOYSA-N 463338 N-[2-(3-chlorophenoxy)ethyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 5 Plasma kallikrein Human 68.4 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463338&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364597 441573184 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956810 Clc1cccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C2CC2)c1 InChI=1S/C28H27ClN4O3/c29-23-4-3-5-24(16-23)36-15-13-30-28(35)25-19-33(31-27(25)22-11-12-22)18-21-9-7-20(8-10-21)17-32-14-2-1-6-26(32)34/h1-10,14,16,19,22H,11-13,15,17-18H2,(H,30,35) IADVHCUBEXJOLV-UHFFFAOYSA-N 463338 N-[2-(3-chlorophenoxy)ethyl]-3-cyclopropyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 5 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463338&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364597 441573184 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956811 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccccc1Cl InChI=1S/C27H27ClN4O4/c1-35-19-24-22(27(34)29-13-15-36-25-7-3-2-6-23(25)28)18-32(30-24)17-21-11-9-20(10-12-21)16-31-14-5-4-8-26(31)33/h2-12,14,18H,13,15-17,19H2,1H3,(H,29,34) WZRSDBUPAAXQBT-UHFFFAOYSA-N 463339 N-[2-(2-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 6 Plasma kallikrein Human 1890 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463339&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364697 441573185 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956812 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccccc1Cl InChI=1S/C27H27ClN4O4/c1-35-19-24-22(27(34)29-13-15-36-25-7-3-2-6-23(25)28)18-32(30-24)17-21-11-9-20(10-12-21)16-31-14-5-4-8-26(31)33/h2-12,14,18H,13,15-17,19H2,1H3,(H,29,34) WZRSDBUPAAXQBT-UHFFFAOYSA-N 463339 N-[2-(2-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 6 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463339&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364697 441573185 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956813 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C27H27ClN4O4/c1-35-19-25-24(27(34)29-12-14-36-23-6-4-5-22(28)15-23)18-32(30-25)17-21-10-8-20(9-11-21)16-31-13-3-2-7-26(31)33/h2-11,13,15,18H,12,14,16-17,19H2,1H3,(H,29,34) XNKYTFKDKMLPMD-UHFFFAOYSA-N 463340 N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 8 Plasma kallikrein Human 16.6 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463340&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364684 441573186 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956814 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C27H27ClN4O4/c1-35-19-25-24(27(34)29-12-14-36-23-6-4-5-22(28)15-23)18-32(30-25)17-21-10-8-20(9-11-21)16-31-13-3-2-7-26(31)33/h2-11,13,15,18H,12,14,16-17,19H2,1H3,(H,29,34) XNKYTFKDKMLPMD-UHFFFAOYSA-N 463340 N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 8 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463340&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364684 441573186 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956815 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1F InChI=1S/C27H26ClFN4O4/c1-36-18-24-22(27(35)30-11-13-37-25-14-21(28)9-10-23(25)29)17-33(31-24)16-20-7-5-19(6-8-20)15-32-12-3-2-4-26(32)34/h2-10,12,14,17H,11,13,15-16,18H2,1H3,(H,30,35) VSFNMIHOXZTLHK-UHFFFAOYSA-N 463341 N-[2-(5-chloro-2-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 9 Plasma kallikrein Human 191 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463341&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364614 441573187 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956816 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1F InChI=1S/C27H26ClFN4O4/c1-36-18-24-22(27(35)30-11-13-37-25-14-21(28)9-10-23(25)29)17-33(31-24)16-20-7-5-19(6-8-20)15-32-12-3-2-4-26(32)34/h2-10,12,14,17H,11,13,15-16,18H2,1H3,(H,30,35) VSFNMIHOXZTLHK-UHFFFAOYSA-N 463341 N-[2-(5-chloro-2-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 9 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463341&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364614 441573187 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956817 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(F)cc(Cl)c1 InChI=1S/C27H26ClFN4O4/c1-36-18-25-24(27(35)30-9-11-37-23-13-21(28)12-22(29)14-23)17-33(31-25)16-20-7-5-19(6-8-20)15-32-10-3-2-4-26(32)34/h2-8,10,12-14,17H,9,11,15-16,18H2,1H3,(H,30,35) PESKEKJIRKNHGR-UHFFFAOYSA-N 463342 N-[2-(3-chloro-5-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 10 Plasma kallikrein Human 134 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463342&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364644 441573188 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956818 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(F)cc(Cl)c1 InChI=1S/C27H26ClFN4O4/c1-36-18-25-24(27(35)30-9-11-37-23-13-21(28)12-22(29)14-23)17-33(31-25)16-20-7-5-19(6-8-20)15-32-10-3-2-4-26(32)34/h2-8,10,12-14,17H,9,11,15-16,18H2,1H3,(H,30,35) PESKEKJIRKNHGR-UHFFFAOYSA-N 463342 N-[2-(3-chloro-5-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 10 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463342&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364644 441573188 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956819 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cc(OC)c1 InChI=1S/C28H29ClN4O5/c1-36-19-26-25(28(35)30-10-12-38-24-14-22(29)13-23(15-24)37-2)18-33(31-26)17-21-8-6-20(7-9-21)16-32-11-4-3-5-27(32)34/h3-9,11,13-15,18H,10,12,16-17,19H2,1-2H3,(H,30,35) OJDVRNWBYOTOAD-UHFFFAOYSA-N 463343 N-[2-(3-chloro-5-methoxyphenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 11 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463343&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364623 441573189 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956820 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cc(OC)c1 InChI=1S/C28H29ClN4O5/c1-36-19-26-25(28(35)30-10-12-38-24-14-22(29)13-23(15-24)37-2)18-33(31-26)17-21-8-6-20(7-9-21)16-32-11-4-3-5-27(32)34/h3-9,11,13-15,18H,10,12,16-17,19H2,1-2H3,(H,30,35) OJDVRNWBYOTOAD-UHFFFAOYSA-N 463343 N-[2-(3-chloro-5-methoxyphenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 11 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463343&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364623 441573189 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956821 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccc(F)c(Cl)c1 InChI=1S/C27H26ClFN4O4/c1-36-18-25-22(27(35)30-11-13-37-21-9-10-24(29)23(28)14-21)17-33(31-25)16-20-7-5-19(6-8-20)15-32-12-3-2-4-26(32)34/h2-10,12,14,17H,11,13,15-16,18H2,1H3,(H,30,35) YUQJMTWNZZCIDE-UHFFFAOYSA-N 463344 N-[2-(3-chloro-4-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 12 Plasma kallikrein Human 266 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463344&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364572 441573190 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956822 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccc(F)c(Cl)c1 InChI=1S/C27H26ClFN4O4/c1-36-18-25-22(27(35)30-11-13-37-21-9-10-24(29)23(28)14-21)17-33(31-25)16-20-7-5-19(6-8-20)15-32-12-3-2-4-26(32)34/h2-10,12,14,17H,11,13,15-16,18H2,1H3,(H,30,35) YUQJMTWNZZCIDE-UHFFFAOYSA-N 463344 N-[2-(3-chloro-4-fluorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 12 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463344&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364572 441573190 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956823 Cc1ccc(Cl)cc1OCCNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N InChI=1S/C26H26ClN5O3/c1-18-5-10-21(27)14-23(18)35-13-11-29-26(34)22-17-32(30-25(22)28)16-20-8-6-19(7-9-20)15-31-12-3-2-4-24(31)33/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,34) HIPKPQWZXBVAPK-UHFFFAOYSA-N 463346 3-amino-N-[2-(5-chloro-2-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 14 Plasma kallikrein Human 161 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463346&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364628 441573192 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956824 Cc1ccc(Cl)cc1OCCNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N InChI=1S/C26H26ClN5O3/c1-18-5-10-21(27)14-23(18)35-13-11-29-26(34)22-17-32(30-25(22)28)16-20-8-6-19(7-9-20)15-31-12-3-2-4-24(31)33/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,34) HIPKPQWZXBVAPK-UHFFFAOYSA-N 463346 3-amino-N-[2-(5-chloro-2-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 14 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463346&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364628 441573192 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956825 Cc1ccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)cc1Cl InChI=1S/C26H26ClN5O3/c1-18-5-10-21(14-23(18)27)35-13-11-29-26(34)22-17-32(30-25(22)28)16-20-8-6-19(7-9-20)15-31-12-3-2-4-24(31)33/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,34) UAYOLTXUOBQDMG-UHFFFAOYSA-N 463347 3-amlno-N-[2-(3-chloro-4-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 15 Plasma kallikrein Human 24.6 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463347&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364584 441573193 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956826 Cc1ccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)cc1Cl InChI=1S/C26H26ClN5O3/c1-18-5-10-21(14-23(18)27)35-13-11-29-26(34)22-17-32(30-25(22)28)16-20-8-6-19(7-9-20)15-31-12-3-2-4-24(31)33/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,34) UAYOLTXUOBQDMG-UHFFFAOYSA-N 463347 3-amlno-N-[2-(3-chloro-4-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 15 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463347&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364584 441573193 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956827 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1Cl InChI=1S/C25H23Cl2N5O3/c26-20-4-3-5-21(23(20)27)35-13-11-29-25(34)19-16-32(30-24(19)28)15-18-9-7-17(8-10-18)14-31-12-2-1-6-22(31)33/h1-10,12,16H,11,13-15H2,(H2,28,30)(H,29,34) ZGCKBZMPZCZLKY-UHFFFAOYSA-N 463348 3-amino-N-[2-(2,3-dichlorophenoxy}ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 29 Plasma kallikrein Human 2930 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463348&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017320 441573194 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956828 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1Cl InChI=1S/C25H23Cl2N5O3/c26-20-4-3-5-21(23(20)27)35-13-11-29-25(34)19-16-32(30-24(19)28)15-18-9-7-17(8-10-18)14-31-12-2-1-6-22(31)33/h1-10,12,16H,11,13-15H2,(H2,28,30)(H,29,34) ZGCKBZMPZCZLKY-UHFFFAOYSA-N 463348 3-amino-N-[2-(2,3-dichlorophenoxy}ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 29 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463348&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017320 441573194 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956829 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccc(Cl)c(Cl)c1 InChI=1S/C25H23Cl2N5O3/c26-21-9-8-19(13-22(21)27)35-12-10-29-25(34)20-16-32(30-24(20)28)15-18-6-4-17(5-7-18)14-31-11-2-1-3-23(31)33/h1-9,11,13,16H,10,12,14-15H2,(H2,28,30)(H,29,34) SPBVCSNNKRGRGB-UHFFFAOYSA-N 463349 3-amino-N-[2-(3,4-dichlorophenoxy}ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 30 Plasma kallikrein Human 96.8 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463349&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364637 441573195 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956830 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1ccc(Cl)c(Cl)c1 InChI=1S/C25H23Cl2N5O3/c26-21-9-8-19(13-22(21)27)35-12-10-29-25(34)20-16-32(30-24(20)28)15-18-6-4-17(5-7-18)14-31-11-2-1-3-23(31)33/h1-9,11,13,16H,10,12,14-15H2,(H2,28,30)(H,29,34) SPBVCSNNKRGRGB-UHFFFAOYSA-N 463349 3-amino-N-[2-(3,4-dichlorophenoxy}ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 30 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463349&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364637 441573195 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956831 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cc(Cl)c1 InChI=1S/C25H23Cl2N5O3/c26-19-11-20(27)13-21(12-19)35-10-8-29-25(34)22-16-32(30-24(22)28)15-18-6-4-17(5-7-18)14-31-9-2-1-3-23(31)33/h1-7,9,11-13,16H,8,10,14-15H2,(H2,28,30)(H,29,34) WQUFZLCASNVIRK-UHFFFAOYSA-N 463350 3-amino-N-[2-(3,5-dichlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 31 Plasma kallikrein Human 646 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463350&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017339 441573196 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956832 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cc(Cl)c1 InChI=1S/C25H23Cl2N5O3/c26-19-11-20(27)13-21(12-19)35-10-8-29-25(34)22-16-32(30-24(22)28)15-18-6-4-17(5-7-18)14-31-9-2-1-3-23(31)33/h1-7,9,11-13,16H,8,10,14-15H2,(H2,28,30)(H,29,34) WQUFZLCASNVIRK-UHFFFAOYSA-N 463350 3-amino-N-[2-(3,5-dichlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 31 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463350&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017339 441573196 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956833 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1C#N InChI=1S/C26H23ClN6O3/c27-21-9-8-20(14-28)23(13-21)36-12-10-30-26(35)22-17-33(31-25(22)29)16-19-6-4-18(5-7-19)15-32-11-2-1-3-24(32)34/h1-9,11,13,17H,10,12,15-16H2,(H2,29,31)(H,30,35) PXPGXHDNNKEEMC-UHFFFAOYSA-N 463351 3-amino-N-[2-(5-chloro-2-cyanophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 32 Plasma kallikrein Human 10.1 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463351&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364653 441573197 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956834 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1C#N InChI=1S/C26H23ClN6O3/c27-21-9-8-20(14-28)23(13-21)36-12-10-30-26(35)22-17-33(31-25(22)29)16-19-6-4-18(5-7-19)15-32-11-2-1-3-24(32)34/h1-9,11,13,17H,10,12,15-16H2,(H2,29,31)(H,30,35) PXPGXHDNNKEEMC-UHFFFAOYSA-N 463351 3-amino-N-[2-(5-chloro-2-cyanophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 32 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463351&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364653 441573197 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956835 Cc1cc(Cl)cc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1 InChI=1S/C26H26ClN5O3/c1-18-12-21(27)14-22(13-18)35-11-9-29-26(34)23-17-32(30-25(23)28)16-20-7-5-19(6-8-20)15-31-10-3-2-4-24(31)33/h2-8,10,12-14,17H,9,11,15-16H2,1H3,(H2,28,30)(H,29,34) MXRZHBPGBXCCGR-UHFFFAOYSA-N 463352 3-amino-N-[2-(3-chloro-5-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 33 Plasma kallikrein Human 114 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463352&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364632 441573198 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956836 Cc1cc(Cl)cc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2N)c1 InChI=1S/C26H26ClN5O3/c1-18-12-21(27)14-22(13-18)35-11-9-29-26(34)23-17-32(30-25(23)28)16-20-7-5-19(6-8-20)15-31-10-3-2-4-24(31)33/h2-8,10,12-14,17H,9,11,15-16H2,1H3,(H2,28,30)(H,29,34) MXRZHBPGBXCCGR-UHFFFAOYSA-N 463352 3-amino-N-[2-(3-chloro-5-methylphenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 33 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463352&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364632 441573198 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956837 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1Cl InChI=1S/C25H23Cl2N5O3/c26-19-8-9-21(27)22(13-19)35-12-10-29-25(34)20-16-32(30-24(20)28)15-18-6-4-17(5-7-18)14-31-11-2-1-3-23(31)33/h1-9,11,13,16H,10,12,14-15H2,(H2,28,30)(H,29,34) VUXFPZIXXCCTOE-UHFFFAOYSA-N 463353 3-amino-N-[2-(2,5-dichlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 34 Plasma kallikrein Human 92.8 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463353&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364640 441573199 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956838 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)ccc1Cl InChI=1S/C25H23Cl2N5O3/c26-19-8-9-21(27)22(13-19)35-12-10-29-25(34)20-16-32(30-24(20)28)15-18-6-4-17(5-7-18)14-31-11-2-1-3-23(31)33/h1-9,11,13,16H,10,12,14-15H2,(H2,28,30)(H,29,34) VUXFPZIXXCCTOE-UHFFFAOYSA-N 463353 3-amino-N-[2-(2,5-dichlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 34 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463353&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364640 441573199 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956839 CN(C)c1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C27H28ClN5O3/c1-31(2)26-24(27(35)29-13-15-36-23-7-5-6-22(28)16-23)19-33(30-26)18-21-11-9-20(10-12-21)17-32-14-4-3-8-25(32)34/h3-12,14,16,19H,13,15,17-18H2,1-2H3,(H,29,35) RNNNIPHZWHWPLM-UHFFFAOYSA-N 463354 N-[2-(3-chlorophenoxy)ethyl]-3-(dimethylamino)-1-({4-[(2-oxopyridin-1-::US10781181, Example 35 Plasma kallikrein Human 122 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463354&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364590 441573200 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956840 CN(C)c1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C27H28ClN5O3/c1-31(2)26-24(27(35)29-13-15-36-23-7-5-6-22(28)16-23)19-33(30-26)18-21-11-9-20(10-12-21)17-32-14-4-3-8-25(32)34/h3-12,14,16,19H,13,15,17-18H2,1-2H3,(H,29,35) RNNNIPHZWHWPLM-UHFFFAOYSA-N 463354 N-[2-(3-chlorophenoxy)ethyl]-3-(dimethylamino)-1-({4-[(2-oxopyridin-1-::US10781181, Example 35 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463354&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364590 441573200 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956841 Clc1cccc(OCCNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1 InChI=1S/C25H23ClN4O3/c26-22-4-3-5-23(14-22)33-13-11-27-25(32)21-15-28-30(18-21)17-20-9-7-19(8-10-20)16-29-12-2-1-6-24(29)31/h1-10,12,14-15,18H,11,13,16-17H2,(H,27,32) YTKAVTOCDDALCO-UHFFFAOYSA-N 463355 N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 36 Plasma kallikrein Human 6.10 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463355&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364612 441573201 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956842 Clc1cccc(OCCNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1 InChI=1S/C25H23ClN4O3/c26-22-4-3-5-23(14-22)33-13-11-27-25(32)21-15-28-30(18-21)17-20-9-7-19(8-10-20)16-29-12-2-1-6-24(29)31/h1-10,12,14-15,18H,11,13,16-17H2,(H,27,32) YTKAVTOCDDALCO-UHFFFAOYSA-N 463355 N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 36 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463355&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364612 441573201 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956843 Clc1cccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C#N)c1 InChI=1S/C26H22ClN5O3/c27-21-4-3-5-22(14-21)35-13-11-29-26(34)23-18-32(30-24(23)15-28)17-20-9-7-19(8-10-20)16-31-12-2-1-6-25(31)33/h1-10,12,14,18H,11,13,16-17H2,(H,29,34) KPMIBBMTUQEJQB-UHFFFAOYSA-N 463356 N-[2-(3-chlorophenoxy)ethyl]-3-cyano-1-({4-[(2-oxopyridin-1-::US10781181, Example 38 Plasma kallikrein Human 6.50 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463356&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364586 441573202 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956844 Clc1cccc(OCCNC(=O)c2cn(Cc3ccc(Cn4ccccc4=O)cc3)nc2C#N)c1 InChI=1S/C26H22ClN5O3/c27-21-4-3-5-22(14-21)35-13-11-29-26(34)23-18-32(30-24(23)15-28)17-20-9-7-19(8-10-20)16-31-12-2-1-6-25(31)33/h1-10,12,14,18H,11,13,16-17H2,(H,29,34) KPMIBBMTUQEJQB-UHFFFAOYSA-N 463356 N-[2-(3-chlorophenoxy)ethyl]-3-cyano-1-({4-[(2-oxopyridin-1-::US10781181, Example 38 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463356&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364586 441573202 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956845 Cc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H25ClN4O3/c1-19-24(26(33)28-12-14-34-23-6-4-5-22(27)15-23)18-31(29-19)17-21-10-8-20(9-11-21)16-30-13-3-2-7-25(30)32/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,33) PKQDYDRNWWAIES-UHFFFAOYSA-N 463357 N-[2-(3-chlorophenoxy)ethyl]-3-methyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 39 Plasma kallikrein Human 16.3 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463357&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364647 441573203 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956846 Cc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H25ClN4O3/c1-19-24(26(33)28-12-14-34-23-6-4-5-22(27)15-23)18-31(29-19)17-21-10-8-20(9-11-21)16-30-13-3-2-7-25(30)32/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,33) PKQDYDRNWWAIES-UHFFFAOYSA-N 463357 N-[2-(3-chlorophenoxy)ethyl]-3-methyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 39 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463357&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364647 441573203 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956847 CN(C(=O)CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)c1cccc(Cl)c1 InChI=1S/C26H25ClN6O3/c1-31(21-6-4-5-20(27)13-21)24(35)14-29-26(36)22-17-33(30-25(22)28)16-19-10-8-18(9-11-19)15-32-12-3-2-7-23(32)34/h2-13,17H,14-16H2,1H3,(H2,28,30)(H,29,36) RQXNPQQKWSXANB-UHFFFAOYSA-N 463358 2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 40 Plasma kallikrein Human 12.6 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463358&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364692 441573204 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956848 CN(C(=O)CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)c1cccc(Cl)c1 InChI=1S/C26H25ClN6O3/c1-31(21-6-4-5-20(27)13-21)24(35)14-29-26(36)22-17-33(30-25(22)28)16-19-10-8-18(9-11-19)15-32-12-3-2-7-23(32)34/h2-13,17H,14-16H2,1H3,(H2,28,30)(H,29,36) RQXNPQQKWSXANB-UHFFFAOYSA-N 463358 2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-yl]formamido}-::US10781181, Example 40 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463358&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364692 441573204 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956849 CN(CCNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)c1cccc(Cl)c1 InChI=1S/C26H27ClN6O2/c1-31(22-6-4-5-21(27)15-22)14-12-29-26(35)23-18-33(30-25(23)28)17-20-10-8-19(9-11-20)16-32-13-3-2-7-24(32)34/h2-11,13,15,18H,12,14,16-17H2,1H3,(H2,28,30)(H,29,35) XWTAAEHIDPTKOV-UHFFFAOYSA-N 463359 3-amino-N-{2-[(3-chlorophenyl)(methyl)amino]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 41 Plasma kallikrein Human 264 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463359&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364625 441573205 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956850 CN(CCNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)c1cccc(Cl)c1 InChI=1S/C26H27ClN6O2/c1-31(22-6-4-5-21(27)15-22)14-12-29-26(35)23-18-33(30-25(23)28)17-20-10-8-19(9-11-20)16-32-13-3-2-7-24(32)34/h2-11,13,15,18H,12,14,16-17H2,1H3,(H2,28,30)(H,29,35) XWTAAEHIDPTKOV-UHFFFAOYSA-N 463359 3-amino-N-{2-[(3-chlorophenyl)(methyl)amino]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 41 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463359&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364625 441573205 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956851 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCCc1cccc(Cl)c1 InChI=1S/C26H26ClN5O2/c27-22-7-3-5-19(15-22)6-4-13-29-26(34)23-18-32(30-25(23)28)17-21-11-9-20(10-12-21)16-31-14-2-1-8-24(31)33/h1-3,5,7-12,14-15,18H,4,6,13,16-17H2,(H2,28,30)(H,29,34) SWKMBJSNIGEHAD-UHFFFAOYSA-N 463360 3-amino-N-[3-(3-chlorophenyl)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 42 Plasma kallikrein Human 3.20 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463360&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364656 441573206 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956852 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCCc1cccc(Cl)c1 InChI=1S/C26H26ClN5O2/c27-22-7-3-5-19(15-22)6-4-13-29-26(34)23-18-32(30-25(23)28)17-21-11-9-20(10-12-21)16-31-14-2-1-8-24(31)33/h1-3,5,7-12,14-15,18H,4,6,13,16-17H2,(H2,28,30)(H,29,34) SWKMBJSNIGEHAD-UHFFFAOYSA-N 463360 3-amino-N-[3-(3-chlorophenyl)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 42 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463360&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364656 441573206 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956853 Cc1nc(cn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H25ClN4O3/c1-19-29-24(26(33)28-12-14-34-23-6-4-5-22(27)15-23)18-31(19)17-21-10-8-20(9-11-21)16-30-13-3-2-7-25(30)32/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,33) BDVFOCNCBZMLBI-UHFFFAOYSA-N 463361 N-[2-(3-chlorophenoxy)ethyl]-2-methyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 43 Plasma kallikrein Human 77.0 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463361&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364615 441573207 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956854 Cc1nc(cn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H25ClN4O3/c1-19-29-24(26(33)28-12-14-34-23-6-4-5-22(27)15-23)18-31(19)17-21-10-8-20(9-11-21)16-30-13-3-2-7-25(30)32/h2-11,13,15,18H,12,14,16-17H2,1H3,(H,28,33) BDVFOCNCBZMLBI-UHFFFAOYSA-N 463361 N-[2-(3-chlorophenoxy)ethyl]-2-methyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 43 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463361&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364615 441573207 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956855 Nc1c(cnn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-15-29-31(24(22)27)17-19-9-7-18(8-10-19)16-30-12-2-1-6-23(30)32/h1-10,12,14-15H,11,13,16-17,27H2,(H,28,33) LUJNONBRKHAYKZ-UHFFFAOYSA-N 463362 5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 17 Plasma kallikrein Human 96.0 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463362&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364616 441573208 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956856 Nc1c(cnn1Cc1ccc(Cn2ccccc2=O)cc1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H24ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-15-29-31(24(22)27)17-19-9-7-18(8-10-19)16-30-12-2-1-6-23(30)32/h1-10,12,14-15H,11,13,16-17,27H2,(H,28,33) LUJNONBRKHAYKZ-UHFFFAOYSA-N 463362 5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 17 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463362&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364616 441573208 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956857 Nc1c(cnn1Cc1ccc2[nH]ncc2c1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN6O2/c21-15-2-1-3-16(9-15)29-7-6-23-20(28)17-11-25-27(19(17)22)12-13-4-5-18-14(8-13)10-24-26-18/h1-5,8-11H,6-7,12,22H2,(H,23,28)(H,24,26) PKPGYVUOAXVWSZ-UHFFFAOYSA-N 463363 5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-(1H-indazol-5-ylmethyl)pyrazole-4-::US10781181, Example 44 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463363&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 155921791 441573209 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956858 Nc1c(cnn1Cc1ccc2[nH]ncc2c1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN6O2/c21-15-2-1-3-16(9-15)29-7-6-23-20(28)17-11-25-27(19(17)22)12-13-4-5-18-14(8-13)10-24-26-18/h1-5,8-11H,6-7,12,22H2,(H,23,28)(H,24,26) PKPGYVUOAXVWSZ-UHFFFAOYSA-N 463363 5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-(1H-indazol-5-ylmethyl)pyrazole-4-::US10781181, Example 44 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463363&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 155921791 441573209 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956859 Nc1c(cnn1Cc1ccc(cc1)C(=O)N1CCCC1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O3/c25-19-4-3-5-20(14-19)33-13-10-27-23(31)21-15-28-30(22(21)26)16-17-6-8-18(9-7-17)24(32)29-11-1-2-12-29/h3-9,14-15H,1-2,10-13,16,26H2,(H,27,31) DPXIZJYRSZUBHM-UHFFFAOYSA-N 463364 5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrrolidin-1-::US10781181, Example 45 Plasma kallikrein Human 6250 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463364&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364651 441573210 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956860 Nc1c(cnn1Cc1ccc(cc1)C(=O)N1CCCC1)C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O3/c25-19-4-3-5-20(14-19)33-13-10-27-23(31)21-15-28-30(22(21)26)16-17-6-8-18(9-7-17)24(32)29-11-1-2-12-29/h3-9,14-15H,1-2,10-13,16,26H2,(H,27,31) DPXIZJYRSZUBHM-UHFFFAOYSA-N 463364 5-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrrolidin-1-::US10781181, Example 45 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463364&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364651 441573210 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956861 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cncc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-19-11-20(13-27-12-19)34-10-8-28-24(33)21-16-31(29-23(21)26)15-18-6-4-17(5-7-18)14-30-9-2-1-3-22(30)32/h1-7,9,11-13,16H,8,10,14-15H2,(H2,26,29)(H,28,33) LFFMEKTWQQAJFX-UHFFFAOYSA-N 463365 3-amino-N-{2-[(5-chloropyridin-3-yl)oxy]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 18 Plasma kallikrein Human 2010 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463365&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364605 441573211 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956862 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cncc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-19-11-20(13-27-12-19)34-10-8-28-24(33)21-16-31(29-23(21)26)15-18-6-4-17(5-7-18)14-30-9-2-1-3-22(30)32/h1-7,9,11-13,16H,8,10,14-15H2,(H2,26,29)(H,28,33) LFFMEKTWQQAJFX-UHFFFAOYSA-N 463365 3-amino-N-{2-[(5-chloropyridin-3-yl)oxy]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 18 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463365&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364605 441573211 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956863 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCCn1cc(Cl)cn1 InChI=1S/C23H24ClN7O2/c24-19-12-27-30(15-19)11-3-9-26-23(33)20-16-31(28-22(20)25)14-18-7-5-17(6-8-18)13-29-10-2-1-4-21(29)32/h1-2,4-8,10,12,15-16H,3,9,11,13-14H2,(H2,25,28)(H,26,33) UTLZLZRSDCQGSD-UHFFFAOYSA-N 463366 3-amino-N-[3-(4-chloropyrazol-1-yl)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 21 Plasma kallikrein Human 2790 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463366&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364655 441573212 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956864 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCCn1cc(Cl)cn1 InChI=1S/C23H24ClN7O2/c24-19-12-27-30(15-19)11-3-9-26-23(33)20-16-31(28-22(20)25)14-18-7-5-17(6-8-18)13-29-10-2-1-4-21(29)32/h1-2,4-8,10,12,15-16H,3,9,11,13-14H2,(H2,25,28)(H,26,33) UTLZLZRSDCQGSD-UHFFFAOYSA-N 463366 3-amino-N-[3-(4-chloropyrazol-1-yl)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 21 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463366&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364655 441573212 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956865 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cnn1 InChI=1S/C25H25ClN6O4/c1-35-17-22-21(25(34)27-9-11-36-23-12-20(26)13-28-29-23)16-32(30-22)15-19-7-5-18(6-8-19)14-31-10-3-2-4-24(31)33/h2-8,10,12-13,16H,9,11,14-15,17H2,1H3,(H,27,34) YMHBACIIJWPZMP-UHFFFAOYSA-N 463367 N-{2-[(5-chloropyridazin-3-yl)oxy]ethyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 46 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463367&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364603 441573213 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956866 COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCOc1cc(Cl)cnn1 InChI=1S/C25H25ClN6O4/c1-35-17-22-21(25(34)27-9-11-36-23-12-20(26)13-28-29-23)16-32(30-22)15-19-7-5-18(6-8-19)14-31-10-3-2-4-24(31)33/h2-8,10,12-13,16H,9,11,14-15,17H2,1H3,(H,27,34) YMHBACIIJWPZMP-UHFFFAOYSA-N 463367 N-{2-[(5-chloropyridazin-3-yl)oxy]ethyl}-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-::US10781181, Example 46 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463367&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364603 441573213 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956867 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCNc1cc(Cl)ccn1 InChI=1S/C24H24ClN7O2/c25-19-8-9-27-21(13-19)28-10-11-29-24(34)20-16-32(30-23(20)26)15-18-6-4-17(5-7-18)14-31-12-2-1-3-22(31)33/h1-9,12-13,16H,10-11,14-15H2,(H2,26,30)(H,27,28)(H,29,34) CMGOOMKRMVBEPY-UHFFFAOYSA-N 463368 3-amino-N-{2-[(4-chloropyridin-2-yl)amino]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 47 Plasma kallikrein Human 30.1 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463368&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364618 441573214 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956868 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCCNc1cc(Cl)ccn1 InChI=1S/C24H24ClN7O2/c25-19-8-9-27-21(13-19)28-10-11-29-24(34)20-16-32(30-23(20)26)15-18-6-4-17(5-7-18)14-31-12-2-1-3-22(31)33/h1-9,12-13,16H,10-11,14-15H2,(H2,26,30)(H,27,28)(H,29,34) CMGOOMKRMVBEPY-UHFFFAOYSA-N 463368 3-amino-N-{2-[(4-chloropyridin-2-yl)amino]ethyl}-1-({4-[(2-oxopyridin-1-::US10781181, Example 47 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463368&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364618 441573214 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956869 COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H28ClN5O3/c1-19-13-29-31(14-19)15-20-6-8-21(9-7-20)16-32-17-24(25(30-32)18-34-2)26(33)28-10-11-35-23-5-3-4-22(27)12-23/h3-9,12-14,17H,10-11,15-16,18H2,1-2H3,(H,28,33) YBVHXZVNVMGNJH-UHFFFAOYSA-N 463369 N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(4-methylpyrazol-1-::US10781181, Example 27 Plasma kallikrein Human 231 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463369&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364675 441573215 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956870 COCc1nn(Cc2ccc(Cn3cc(C)cn3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C26H28ClN5O3/c1-19-13-29-31(14-19)15-20-6-8-21(9-7-20)16-32-17-24(25(30-32)18-34-2)26(33)28-10-11-35-23-5-3-4-22(27)12-23/h3-9,12-14,17H,10-11,15-16,18H2,1-2H3,(H,28,33) YBVHXZVNVMGNJH-UHFFFAOYSA-N 463369 N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(4-methylpyrazol-1-::US10781181, Example 27 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463369&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364675 441573215 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956871 Cc1cc(C(=O)NCCOc2cccc(Cl)c2)c(C)n1Cc1csc(n1)-c1ccccc1 InChI=1S/C25H24ClN3O2S/c1-17-13-23(24(30)27-11-12-31-22-10-6-9-20(26)14-22)18(2)29(17)15-21-16-32-25(28-21)19-7-4-3-5-8-19/h3-10,13-14,16H,11-12,15H2,1-2H3,(H,27,30) GQHOGBSEMUWETE-UHFFFAOYSA-N 463370 N-[2-(3-chlorophenoxy)ethyl]-2,5-dimethyl-1-[(2-phenyl-1,3-thiazol-4-::US10781181, Example 48 Plasma kallikrein Human 6620 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463370&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017335 441573216 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956872 Cc1cc(C(=O)NCCOc2cccc(Cl)c2)c(C)n1Cc1csc(n1)-c1ccccc1 InChI=1S/C25H24ClN3O2S/c1-17-13-23(24(30)27-11-12-31-22-10-6-9-20(26)14-22)18(2)29(17)15-21-16-32-25(28-21)19-7-4-3-5-8-19/h3-10,13-14,16H,11-12,15H2,1-2H3,(H,27,30) GQHOGBSEMUWETE-UHFFFAOYSA-N 463370 N-[2-(3-chlorophenoxy)ethyl]-2,5-dimethyl-1-[(2-phenyl-1,3-thiazol-4-::US10781181, Example 48 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463370&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017335 441573216 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956873 Nc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H25ClN6O2/c23-17-4-3-5-18(12-17)31-11-8-25-22(30)19-15-29(27-21(19)24)14-16-6-7-20(26-13-16)28-9-1-2-10-28/h3-7,12-13,15H,1-2,8-11,14H2,(H2,24,27)(H,25,30) GLDWFNRLYGEHRT-UHFFFAOYSA-N 463371 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-::US10781181, Example 49 Plasma kallikrein Human 847 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463371&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364648 441573217 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956874 Nc1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H25ClN6O2/c23-17-4-3-5-18(12-17)31-11-8-25-22(30)19-15-29(27-21(19)24)14-16-6-7-20(26-13-16)28-9-1-2-10-28/h3-7,12-13,15H,1-2,8-11,14H2,(H2,24,27)(H,25,30) GLDWFNRLYGEHRT-UHFFFAOYSA-N 463371 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-::US10781181, Example 49 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463371&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364648 441573217 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956875 Nc1nn(Cc2ccnc(c2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H25ClN6O2/c23-17-4-3-5-18(13-17)31-11-8-26-22(30)19-15-29(27-21(19)24)14-16-6-7-25-20(12-16)28-9-1-2-10-28/h3-7,12-13,15H,1-2,8-11,14H2,(H2,24,27)(H,26,30) AZZMPGUGDWTGGN-UHFFFAOYSA-N 463372 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyrrolidin-1-yl)pyridin-4-::US10781181, Example 50 Plasma kallikrein Human 326 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463372&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364617 441573218 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956876 Nc1nn(Cc2ccnc(c2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H25ClN6O2/c23-17-4-3-5-18(13-17)31-11-8-26-22(30)19-15-29(27-21(19)24)14-16-6-7-25-20(12-16)28-9-1-2-10-28/h3-7,12-13,15H,1-2,8-11,14H2,(H2,24,27)(H,26,30) AZZMPGUGDWTGGN-UHFFFAOYSA-N 463372 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyrrolidin-1-yl)pyridin-4-::US10781181, Example 50 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463372&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364617 441573218 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956877 Nc1nn(Cc2ccc(cc2)C(=O)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O3/c25-19-4-3-5-20(14-19)33-13-10-27-23(31)21-16-30(28-22(21)26)15-17-6-8-18(9-7-17)24(32)29-11-1-2-12-29/h3-9,14,16H,1-2,10-13,15H2,(H2,26,28)(H,27,31) SMHRRWCCPUBJDL-UHFFFAOYSA-N 463373 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrrolidin-1-::US10781181, Example 51 Plasma kallikrein Human 427 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463373&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364562 441573219 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956878 Nc1nn(Cc2ccc(cc2)C(=O)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O3/c25-19-4-3-5-20(14-19)33-13-10-27-23(31)21-16-30(28-22(21)26)15-17-6-8-18(9-7-17)24(32)29-11-1-2-12-29/h3-9,14,16H,1-2,10-13,15H2,(H2,26,28)(H,27,31) SMHRRWCCPUBJDL-UHFFFAOYSA-N 463373 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrrolidin-1-::US10781181, Example 51 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463373&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364562 441573219 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956879 Nc1nn(Cc2ccc(cc2)-n2ccccc2=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H22ClN5O3/c25-18-4-3-5-20(14-18)33-13-11-27-24(32)21-16-29(28-23(21)26)15-17-7-9-19(10-8-17)30-12-2-1-6-22(30)31/h1-10,12,14,16H,11,13,15H2,(H2,26,28)(H,27,32) RRMZZTMCFSXHCD-UHFFFAOYSA-N 463374 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-(2-oxopyridin-1-::US10781181, Example 52 Plasma kallikrein Human 335 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463374&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364558 441573220 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956880 Nc1nn(Cc2ccc(cc2)-n2ccccc2=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H22ClN5O3/c25-18-4-3-5-20(14-18)33-13-11-27-24(32)21-16-29(28-23(21)26)15-17-7-9-19(10-8-17)30-12-2-1-6-22(30)31/h1-10,12,14,16H,11,13,15H2,(H2,26,28)(H,27,32) RRMZZTMCFSXHCD-UHFFFAOYSA-N 463374 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-(2-oxopyridin-1-::US10781181, Example 52 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463374&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364558 441573220 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956881 Nc1nn(Cc2cccc(n2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H25ClN6O2/c23-16-5-3-7-18(13-16)31-12-9-25-22(30)19-15-29(27-21(19)24)14-17-6-4-8-20(26-17)28-10-1-2-11-28/h3-8,13,15H,1-2,9-12,14H2,(H2,24,27)(H,25,30) JGWRRCJMVWBQES-UHFFFAOYSA-N 463375 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-2-::US10781181, Example 53 Plasma kallikrein Human 4730 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463375&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364624 441573221 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956882 Nc1nn(Cc2cccc(n2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H25ClN6O2/c23-16-5-3-7-18(13-16)31-12-9-25-22(30)19-15-29(27-21(19)24)14-17-6-4-8-20(26-17)28-10-1-2-11-28/h3-8,13,15H,1-2,9-12,14H2,(H2,24,27)(H,25,30) JGWRRCJMVWBQES-UHFFFAOYSA-N 463375 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-2-::US10781181, Example 53 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463375&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364624 441573221 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956883 Cc1ccc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc2n1 InChI=1S/C23H22ClN5O2/c1-15-5-7-17-11-16(6-8-21(17)27-15)13-29-14-20(22(25)28-29)23(30)26-9-10-31-19-4-2-3-18(24)12-19/h2-8,11-12,14H,9-10,13H2,1H3,(H2,25,28)(H,26,30) KYJDNTKCQHHXSZ-UHFFFAOYSA-N 463376 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-methylquinolin-6-yl)methyl]pyrazole-4-::US10781181, Example 54 Plasma kallikrein Human 245 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463376&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017348 441573222 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956884 Cc1ccc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc2n1 InChI=1S/C23H22ClN5O2/c1-15-5-7-17-11-16(6-8-21(17)27-15)13-29-14-20(22(25)28-29)23(30)26-9-10-31-19-4-2-3-18(24)12-19/h2-8,11-12,14H,9-10,13H2,1H3,(H2,25,28)(H,26,30) KYJDNTKCQHHXSZ-UHFFFAOYSA-N 463376 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-methylquinolin-6-yl)methyl]pyrazole-4-::US10781181, Example 54 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463376&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017348 441573222 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956885 Nc1nn(Cc2ccc(Br)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C19H18BrClN4O2/c20-14-6-4-13(5-7-14)11-25-12-17(18(22)24-25)19(26)23-8-9-27-16-3-1-2-15(21)10-16/h1-7,10,12H,8-9,11H2,(H2,22,24)(H,23,26) WCUWJEOEEQOSKM-UHFFFAOYSA-N 463377 3-amino-1-[(4-bromophenyl)methyl]-N-[2-(3-chlorophenoxy)ethyl]pyrazole-4-::US10781181, Example 55 Plasma kallikrein Human 6410 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463377&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017337 441573223 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956886 Nc1nn(Cc2ccc(Br)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C19H18BrClN4O2/c20-14-6-4-13(5-7-14)11-25-12-17(18(22)24-25)19(26)23-8-9-27-16-3-1-2-15(21)10-16/h1-7,10,12H,8-9,11H2,(H2,22,24)(H,23,26) WCUWJEOEEQOSKM-UHFFFAOYSA-N 463377 3-amino-1-[(4-bromophenyl)methyl]-N-[2-(3-chlorophenoxy)ethyl]pyrazole-4-::US10781181, Example 55 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463377&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017337 441573223 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956887 Nc1nn(Cc2cccc(Br)c2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C19H18BrClN4O2/c20-14-4-1-3-13(9-14)11-25-12-17(18(22)24-25)19(26)23-7-8-27-16-6-2-5-15(21)10-16/h1-6,9-10,12H,7-8,11H2,(H2,22,24)(H,23,26) KGCHKHMBUCVUST-UHFFFAOYSA-N 463378 3-amino-1-[(3-bromophenyl)methyl]-N-[2-(3-chlorophenoxy)ethyl]pyrazole-4-::US10781181, Example 56 Plasma kallikrein Human 8490 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463378&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017364 441573224 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956888 Nc1nn(Cc2cccc(Br)c2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C19H18BrClN4O2/c20-14-4-1-3-13(9-14)11-25-12-17(18(22)24-25)19(26)23-7-8-27-16-6-2-5-15(21)10-16/h1-6,9-10,12H,7-8,11H2,(H2,22,24)(H,23,26) KGCHKHMBUCVUST-UHFFFAOYSA-N 463378 3-amino-1-[(3-bromophenyl)methyl]-N-[2-(3-chlorophenoxy)ethyl]pyrazole-4-::US10781181, Example 56 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463378&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017364 441573224 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956889 Nc1nn(Cc2cccc(c2)-c2cncs2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H20ClN5O2S/c23-17-5-2-6-18(10-17)30-8-7-26-22(29)19-13-28(27-21(19)24)12-15-3-1-4-16(9-15)20-11-25-14-31-20/h1-6,9-11,13-14H,7-8,12H2,(H2,24,27)(H,26,29) GWFWFIUCZRAALU-UHFFFAOYSA-N 463379 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-(1,3-thiazol-5-yl)phenyl]methyl}pyrazole-::US10781181, Example 57 Plasma kallikrein Human 6830 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463379&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017330 441573225 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956890 Nc1nn(Cc2cccc(c2)-c2cncs2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H20ClN5O2S/c23-17-5-2-6-18(10-17)30-8-7-26-22(29)19-13-28(27-21(19)24)12-15-3-1-4-16(9-15)20-11-25-14-31-20/h1-6,9-11,13-14H,7-8,12H2,(H2,24,27)(H,26,29) GWFWFIUCZRAALU-UHFFFAOYSA-N 463379 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-(1,3-thiazol-5-yl)phenyl]methyl}pyrazole-::US10781181, Example 57 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463379&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017330 441573225 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956891 COC(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C21H21ClN4O4/c1-29-21(28)15-7-5-14(6-8-15)12-26-13-18(19(23)25-26)20(27)24-9-10-30-17-4-2-3-16(22)11-17/h2-8,11,13H,9-10,12H2,1H3,(H2,23,25)(H,24,27) VMWNXMNJZZJVIS-UHFFFAOYSA-N 463380 US10781181, Example 58::methyl 4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1- Plasma kallikrein Human 5420 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463380&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364661 441573226 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956892 COC(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C21H21ClN4O4/c1-29-21(28)15-7-5-14(6-8-15)12-26-13-18(19(23)25-26)20(27)24-9-10-30-17-4-2-3-16(22)11-17/h2-8,11,13H,9-10,12H2,1H3,(H2,23,25)(H,24,27) VMWNXMNJZZJVIS-UHFFFAOYSA-N 463380 US10781181, Example 58::methyl 4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1- Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463380&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364661 441573226 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956893 CN(C)C(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C22H24ClN5O3/c1-27(2)22(30)16-8-6-15(7-9-16)13-28-14-19(20(24)26-28)21(29)25-10-11-31-18-5-3-4-17(23)12-18/h3-9,12,14H,10-11,13H2,1-2H3,(H2,24,26)(H,25,29) WPDVWPIECFDCIP-UHFFFAOYSA-N 463381 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-::US10781181, Example 59 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463381&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017327 441573227 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956894 CN(C)C(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C22H24ClN5O3/c1-27(2)22(30)16-8-6-15(7-9-16)13-28-14-19(20(24)26-28)21(29)25-10-11-31-18-5-3-4-17(23)12-18/h3-9,12,14H,10-11,13H2,1-2H3,(H2,24,26)(H,25,29) WPDVWPIECFDCIP-UHFFFAOYSA-N 463381 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-::US10781181, Example 59 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463381&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017327 441573227 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956895 Nc1nn(Cc2ccc(cc2)C(=O)N2CCCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H28ClN5O3/c26-20-5-4-6-21(15-20)34-14-11-28-24(32)22-17-31(29-23(22)27)16-18-7-9-19(10-8-18)25(33)30-12-2-1-3-13-30/h4-10,15,17H,1-3,11-14,16H2,(H2,27,29)(H,28,32) KURGXUOQMFGGER-UHFFFAOYSA-N 463382 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(piperidin-1-::US10781181, Example 60 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463382&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364593 441573228 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956896 Nc1nn(Cc2ccc(cc2)C(=O)N2CCCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H28ClN5O3/c26-20-5-4-6-21(15-20)34-14-11-28-24(32)22-17-31(29-23(22)27)16-18-7-9-19(10-8-18)25(33)30-12-2-1-3-13-30/h4-10,15,17H,1-3,11-14,16H2,(H2,27,29)(H,28,32) KURGXUOQMFGGER-UHFFFAOYSA-N 463382 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(piperidin-1-::US10781181, Example 60 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463382&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364593 441573228 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956897 CNC(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C21H22ClN5O3/c1-24-20(28)15-7-5-14(6-8-15)12-27-13-18(19(23)26-27)21(29)25-9-10-30-17-4-2-3-16(22)11-17/h2-8,11,13H,9-10,12H2,1H3,(H2,23,26)(H,24,28)(H,25,29) GFNAJZVJIOCXDN-UHFFFAOYSA-N 463383 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-::US10781181, Example 61 Plasma kallikrein Human 7250 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463383&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017355 441573229 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956898 CNC(=O)c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C21H22ClN5O3/c1-24-20(28)15-7-5-14(6-8-15)12-27-13-18(19(23)26-27)21(29)25-9-10-30-17-4-2-3-16(22)11-17/h2-8,11,13H,9-10,12H2,1H3,(H2,23,26)(H,24,28)(H,25,29) GFNAJZVJIOCXDN-UHFFFAOYSA-N 463383 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-::US10781181, Example 61 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463383&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017355 441573229 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956899 CCOC(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1 InChI=1S/C22H23ClN4O4/c1-2-30-22(29)16-6-3-5-15(11-16)13-27-14-19(20(24)26-27)21(28)25-9-10-31-18-8-4-7-17(23)12-18/h3-8,11-12,14H,2,9-10,13H2,1H3,(H2,24,26)(H,25,28) KPRMEECKXIGZBV-UHFFFAOYSA-N 463384 US10781181, Example 62::ethyl 3-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1- Plasma kallikrein Human 7150 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463384&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364577 441573230 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956900 CCOC(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1 InChI=1S/C22H23ClN4O4/c1-2-30-22(29)16-6-3-5-15(11-16)13-27-14-19(20(24)26-27)21(28)25-9-10-31-18-8-4-7-17(23)12-18/h3-8,11-12,14H,2,9-10,13H2,1H3,(H2,24,26)(H,25,28) KPRMEECKXIGZBV-UHFFFAOYSA-N 463384 US10781181, Example 62::ethyl 3-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1- Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463384&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364577 441573230 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956901 Nc1nn(Cc2cccc(c2)C(O)=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN4O4/c21-15-5-2-6-16(10-15)29-8-7-23-19(26)17-12-25(24-18(17)22)11-13-3-1-4-14(9-13)20(27)28/h1-6,9-10,12H,7-8,11H2,(H2,22,24)(H,23,26)(H,27,28) BKBNAGUSMQXXCX-UHFFFAOYSA-N 463385 3-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]benzoic acid::US10781181, Example 63 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463385&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364702 441573231 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956902 Nc1nn(Cc2cccc(c2)C(O)=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN4O4/c21-15-5-2-6-16(10-15)29-8-7-23-19(26)17-12-25(24-18(17)22)11-13-3-1-4-14(9-13)20(27)28/h1-6,9-10,12H,7-8,11H2,(H2,22,24)(H,23,26)(H,27,28) BKBNAGUSMQXXCX-UHFFFAOYSA-N 463385 3-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]benzoic acid::US10781181, Example 63 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463385&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364702 441573231 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956903 CNC(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1 InChI=1S/C21H22ClN5O3/c1-24-20(28)15-5-2-4-14(10-15)12-27-13-18(19(23)26-27)21(29)25-8-9-30-17-7-3-6-16(22)11-17/h2-7,10-11,13H,8-9,12H2,1H3,(H2,23,26)(H,24,28)(H,25,29) UHMBFUDKJCHANI-UHFFFAOYSA-N 463386 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-::US10781181, Example 64 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463386&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017365 441573232 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956904 CNC(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1 InChI=1S/C21H22ClN5O3/c1-24-20(28)15-5-2-4-14(10-15)12-27-13-18(19(23)26-27)21(29)25-8-9-30-17-7-3-6-16(22)11-17/h2-7,10-11,13H,8-9,12H2,1H3,(H2,23,26)(H,24,28)(H,25,29) UHMBFUDKJCHANI-UHFFFAOYSA-N 463386 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-::US10781181, Example 64 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463386&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017365 441573232 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956905 CN(C)C(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1 InChI=1S/C22H24ClN5O3/c1-27(2)22(30)16-6-3-5-15(11-16)13-28-14-19(20(24)26-28)21(29)25-9-10-31-18-8-4-7-17(23)12-18/h3-8,11-12,14H,9-10,13H2,1-2H3,(H2,24,26)(H,25,29) GBDMHOKBAITSTR-UHFFFAOYSA-N 463387 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-::US10781181, Example 65 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463387&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017370 441573233 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956906 CN(C)C(=O)c1cccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)c1 InChI=1S/C22H24ClN5O3/c1-27(2)22(30)16-6-3-5-15(11-16)13-28-14-19(20(24)26-28)21(29)25-9-10-31-18-8-4-7-17(23)12-18/h3-8,11-12,14H,9-10,13H2,1-2H3,(H2,24,26)(H,25,29) GBDMHOKBAITSTR-UHFFFAOYSA-N 463387 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[3-::US10781181, Example 65 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463387&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017370 441573233 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956907 Nc1nn(Cc2ccnc(c2)-n2cccn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C21H20ClN7O2/c22-16-3-1-4-17(12-16)31-10-8-25-21(30)18-14-28(27-20(18)23)13-15-5-7-24-19(11-15)29-9-2-6-26-29/h1-7,9,11-12,14H,8,10,13H2,(H2,23,27)(H,25,30) QAJNKGHUEALUSN-UHFFFAOYSA-N 463388 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyrazol-1-yl)pyridin-4-yl]methyl}pyrazole-::US10781181, Example 66 Plasma kallikrein Human 4920 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463388&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364626 441573234 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956908 Nc1nn(Cc2ccnc(c2)-n2cccn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C21H20ClN7O2/c22-16-3-1-4-17(12-16)31-10-8-25-21(30)18-14-28(27-20(18)23)13-15-5-7-24-19(11-15)29-9-2-6-26-29/h1-7,9,11-12,14H,8,10,13H2,(H2,23,27)(H,25,30) QAJNKGHUEALUSN-UHFFFAOYSA-N 463388 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyrazol-1-yl)pyridin-4-yl]methyl}pyrazole-::US10781181, Example 66 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463388&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364626 441573234 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956909 CN(CC(O)=O)c1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1 InChI=1S/C21H23ClN6O4/c1-27(13-19(29)30)18-9-14(5-6-24-18)11-28-12-17(20(23)26-28)21(31)25-7-8-32-16-4-2-3-15(22)10-16/h2-6,9-10,12H,7-8,11,13H2,1H3,(H2,23,26)(H,25,31)(H,29,30) WFNSOYUNKXGJOG-UHFFFAOYSA-N 463389 ({4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]pyridin-2-::US10781181, Example 67 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463389&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364645 441573235 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956910 CN(CC(O)=O)c1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1 InChI=1S/C21H23ClN6O4/c1-27(13-19(29)30)18-9-14(5-6-24-18)11-28-12-17(20(23)26-28)21(31)25-7-8-32-16-4-2-3-15(22)10-16/h2-6,9-10,12H,7-8,11,13H2,1H3,(H2,23,26)(H,25,31)(H,29,30) WFNSOYUNKXGJOG-UHFFFAOYSA-N 463389 ({4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]pyridin-2-::US10781181, Example 67 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463389&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364645 441573235 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956911 CNC(=O)CNc1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1 InChI=1S/C21H24ClN7O3/c1-24-19(30)11-27-18-9-14(5-6-25-18)12-29-13-17(20(23)28-29)21(31)26-7-8-32-16-4-2-3-15(22)10-16/h2-6,9-10,13H,7-8,11-12H2,1H3,(H2,23,28)(H,24,30)(H,25,27)(H,26,31) RZRWVFIJPHJJEA-UHFFFAOYSA-N 463390 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-::US10781181, Example 68 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463390&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017351 441573236 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956912 CNC(=O)CNc1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1 InChI=1S/C21H24ClN7O3/c1-24-19(30)11-27-18-9-14(5-6-25-18)12-29-13-17(20(23)28-29)21(31)26-7-8-32-16-4-2-3-15(22)10-16/h2-6,9-10,13H,7-8,11-12H2,1H3,(H2,23,28)(H,24,30)(H,25,27)(H,26,31) RZRWVFIJPHJJEA-UHFFFAOYSA-N 463390 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-::US10781181, Example 68 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463390&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017351 441573236 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956913 Nc1nn(Cc2ccc(cc2)C(O)=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN4O4/c21-15-2-1-3-16(10-15)29-9-8-23-19(26)17-12-25(24-18(17)22)11-13-4-6-14(7-5-13)20(27)28/h1-7,10,12H,8-9,11H2,(H2,22,24)(H,23,26)(H,27,28) IGGDLOGITQRPBW-UHFFFAOYSA-N 463391 4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]benzoic acid::US10781181, Example 69 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463391&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364574 441573237 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956914 Nc1nn(Cc2ccc(cc2)C(O)=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN4O4/c21-15-2-1-3-16(10-15)29-9-8-23-19(26)17-12-25(24-18(17)22)11-13-4-6-14(7-5-13)20(27)28/h1-7,10,12H,8-9,11H2,(H2,22,24)(H,23,26)(H,27,28) IGGDLOGITQRPBW-UHFFFAOYSA-N 463391 4-[(3-amino-4-{[2-(3-chlorophenoxy)ethyl]carbamoyl}pyrazol-1-yl)methyl]benzoic acid::US10781181, Example 69 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463391&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364574 441573237 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956915 Nc1nn(Cc2cccc(c2)C(=O)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O3/c25-19-7-4-8-20(14-19)33-12-9-27-23(31)21-16-30(28-22(21)26)15-17-5-3-6-18(13-17)24(32)29-10-1-2-11-29/h3-8,13-14,16H,1-2,9-12,15H2,(H2,26,28)(H,27,31) FDSBGTCPRVRSDQ-UHFFFAOYSA-N 463392 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({3-[(pyrrolidin-1-::US10781181, Example 70 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463392&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364564 441573238 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956916 Nc1nn(Cc2cccc(c2)C(=O)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O3/c25-19-7-4-8-20(14-19)33-12-9-27-23(31)21-16-30(28-22(21)26)15-17-5-3-6-18(13-17)24(32)29-10-1-2-11-29/h3-8,13-14,16H,1-2,9-12,15H2,(H2,26,28)(H,27,31) FDSBGTCPRVRSDQ-UHFFFAOYSA-N 463392 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({3-[(pyrrolidin-1-::US10781181, Example 70 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463392&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364564 441573238 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956917 Nc1nn(Cc2ccc(Oc3ccccc3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClN4O3/c26-19-5-4-8-22(15-19)32-14-13-28-25(31)23-17-30(29-24(23)27)16-18-9-11-21(12-10-18)33-20-6-2-1-3-7-20/h1-12,15,17H,13-14,16H2,(H2,27,29)(H,28,31) AMXRUKQUJVHMDM-UHFFFAOYSA-N 463393 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-phenoxyphenyl)methyl]pyrazole-4-::US10781181, Example 71 Plasma kallikrein Human 2070 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463393&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017359 441573239 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956918 Nc1nn(Cc2ccc(Oc3ccccc3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClN4O3/c26-19-5-4-8-22(15-19)32-14-13-28-25(31)23-17-30(29-24(23)27)16-18-9-11-21(12-10-18)33-20-6-2-1-3-7-20/h1-12,15,17H,13-14,16H2,(H2,27,29)(H,28,31) AMXRUKQUJVHMDM-UHFFFAOYSA-N 463393 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-phenoxyphenyl)methyl]pyrazole-4-::US10781181, Example 71 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463393&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017359 441573239 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956919 Nc1nn(Cc2cccc(n2)-c2ccccc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H22ClN5O2/c25-18-8-4-10-20(14-18)32-13-12-27-24(31)21-16-30(29-23(21)26)15-19-9-5-11-22(28-19)17-6-2-1-3-7-17/h1-11,14,16H,12-13,15H2,(H2,26,29)(H,27,31) GHIFXYCOHYHNQO-UHFFFAOYSA-N 463394 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-phenylpyridin-2-yl)methyl]pyrazole-4-::US10781181, Example 72 Plasma kallikrein Human 5940 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463394&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017347 441573240 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956920 Nc1nn(Cc2cccc(n2)-c2ccccc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H22ClN5O2/c25-18-8-4-10-20(14-18)32-13-12-27-24(31)21-16-30(29-23(21)26)15-19-9-5-11-22(28-19)17-6-2-1-3-7-17/h1-11,14,16H,12-13,15H2,(H2,26,29)(H,27,31) GHIFXYCOHYHNQO-UHFFFAOYSA-N 463394 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-phenylpyridin-2-yl)methyl]pyrazole-4-::US10781181, Example 72 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463394&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017347 441573240 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956921 Nc1nn(Cc2ccnc(O)c2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C18H18ClN5O3/c19-13-2-1-3-14(9-13)27-7-6-22-18(26)15-11-24(23-17(15)20)10-12-4-5-21-16(25)8-12/h1-5,8-9,11H,6-7,10H2,(H2,20,23)(H,21,25)(H,22,26) TXXBXGLFCIWMSJ-UHFFFAOYSA-N 463395 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-methoxypyridin-4-yl)methyl]pyrazole-4-::US10781181, Example 73 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463395&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 155921792 441573241 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956922 Nc1nn(Cc2ccnc(O)c2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C18H18ClN5O3/c19-13-2-1-3-14(9-13)27-7-6-22-18(26)15-11-24(23-17(15)20)10-12-4-5-21-16(25)8-12/h1-5,8-9,11H,6-7,10H2,(H2,20,23)(H,21,25)(H,22,26) TXXBXGLFCIWMSJ-UHFFFAOYSA-N 463395 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-methoxypyridin-4-yl)methyl]pyrazole-4-::US10781181, Example 73 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463395&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 155921792 441573241 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956923 CNC(=O)CN(C)c1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1 InChI=1S/C22H26ClN7O3/c1-25-20(31)14-29(2)19-10-15(6-7-26-19)12-30-13-18(21(24)28-30)22(32)27-8-9-33-17-5-3-4-16(23)11-17/h3-7,10-11,13H,8-9,12,14H2,1-2H3,(H2,24,28)(H,25,31)(H,27,32) BLLCAAPQWVZPQS-UHFFFAOYSA-N 463396 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-::US10781181, Example 74 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463396&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017342 441573242 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956924 CNC(=O)CN(C)c1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccn1 InChI=1S/C22H26ClN7O3/c1-25-20(31)14-29(2)19-10-15(6-7-26-19)12-30-13-18(21(24)28-30)22(32)27-8-9-33-17-5-3-4-16(23)11-17/h3-7,10-11,13H,8-9,12,14H2,1-2H3,(H2,24,28)(H,25,31)(H,27,32) BLLCAAPQWVZPQS-UHFFFAOYSA-N 463396 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(2-::US10781181, Example 74 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463396&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017342 441573242 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956925 Nc1nn(Cc2ccc(COc3ncccn3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-19-3-1-4-20(13-19)33-12-11-27-23(32)21-15-31(30-22(21)26)14-17-5-7-18(8-6-17)16-34-24-28-9-2-10-29-24/h1-10,13,15H,11-12,14,16H2,(H2,26,30)(H,27,32) YIZFEKGERFZRIT-UHFFFAOYSA-N 463397 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrimidin-2-::US10781181, Example 75 Plasma kallikrein Human 3670 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463397&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017329 441573243 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956926 Nc1nn(Cc2ccc(COc3ncccn3)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-19-3-1-4-20(13-19)33-12-11-27-23(32)21-15-31(30-22(21)26)14-17-5-7-18(8-6-17)16-34-24-28-9-2-10-29-24/h1-10,13,15H,11-12,14,16H2,(H2,26,30)(H,27,32) YIZFEKGERFZRIT-UHFFFAOYSA-N 463397 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(pyrimidin-2-::US10781181, Example 75 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463397&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017329 441573243 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956927 Nc1nn(Cc2ccc(CN3CCOCC3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O4/c25-19-2-1-3-20(12-19)34-10-8-27-24(32)21-15-30(28-23(21)26)14-18-6-4-17(5-7-18)13-29-9-11-33-16-22(29)31/h1-7,12,15H,8-11,13-14,16H2,(H2,26,28)(H,27,32) ZQQDEPIFGBWRCU-UHFFFAOYSA-N 463398 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(3-oxomorpholin-4-::US10781181, Example 76 Plasma kallikrein Human 227 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463398&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017319 441573244 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956928 Nc1nn(Cc2ccc(CN3CCOCC3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H26ClN5O4/c25-19-2-1-3-20(12-19)34-10-8-27-24(32)21-15-30(28-23(21)26)14-18-6-4-17(5-7-18)13-29-9-11-33-16-22(29)31/h1-7,12,15H,8-11,13-14,16H2,(H2,26,28)(H,27,32) ZQQDEPIFGBWRCU-UHFFFAOYSA-N 463398 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(3-oxomorpholin-4-::US10781181, Example 76 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463398&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017319 441573244 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956929 Nc1nn(Cc2ccc(CN3CCCCC3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H28ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h3-5,7-10,14,17H,1-2,6,11-13,15-16H2,(H2,27,29)(H,28,33) ODYDFHAUZLVWPR-UHFFFAOYSA-N 463399 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopiperidin-1-::US10781181, Example 77 Plasma kallikrein Human 112 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463399&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364598 441573245 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956930 Nc1nn(Cc2ccc(CN3CCCCC3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H28ClN5O3/c26-20-4-3-5-21(14-20)34-13-11-28-25(33)22-17-31(29-24(22)27)16-19-9-7-18(8-10-19)15-30-12-2-1-6-23(30)32/h3-5,7-10,14,17H,1-2,6,11-13,15-16H2,(H2,27,29)(H,28,33) ODYDFHAUZLVWPR-UHFFFAOYSA-N 463399 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopiperidin-1-::US10781181, Example 77 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463399&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364598 441573245 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956931 CNC(=O)CNc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cn1 InChI=1S/C21H24ClN7O3/c1-24-19(30)11-27-18-6-5-14(10-26-18)12-29-13-17(20(23)28-29)21(31)25-7-8-32-16-4-2-3-15(22)9-16/h2-6,9-10,13H,7-8,11-12H2,1H3,(H2,23,28)(H,24,30)(H,25,31)(H,26,27) BURQMAPZDBUBPP-UHFFFAOYSA-N 463400 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-::US10781181, Example 78 Plasma kallikrein Human 6930 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463400&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017324 441573246 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956932 CNC(=O)CNc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cn1 InChI=1S/C21H24ClN7O3/c1-24-19(30)11-27-18-6-5-14(10-26-18)12-29-13-17(20(23)28-29)21(31)25-7-8-32-16-4-2-3-15(22)9-16/h2-6,9-10,13H,7-8,11-12H2,1H3,(H2,23,28)(H,24,30)(H,25,31)(H,26,27) BURQMAPZDBUBPP-UHFFFAOYSA-N 463400 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-::US10781181, Example 78 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463400&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017324 441573246 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956933 Nc1nn(Cc2ccc(cc2)-c2ncccn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H21ClN6O2/c24-18-3-1-4-19(13-18)32-12-11-28-23(31)20-15-30(29-21(20)25)14-16-5-7-17(8-6-16)22-26-9-2-10-27-22/h1-10,13,15H,11-12,14H2,(H2,25,29)(H,28,31) LACQOZQIBKGKTF-UHFFFAOYSA-N 463401 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-(pyrimidin-2-yl)phenyl]methyl}pyrazole-4-::US10781181, Example 79 Plasma kallikrein Human 5870 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463401&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017328 441573247 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956934 Nc1nn(Cc2ccc(cc2)-c2ncccn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H21ClN6O2/c24-18-3-1-4-19(13-18)32-12-11-28-23(31)20-15-30(29-21(20)25)14-16-5-7-17(8-6-16)22-26-9-2-10-27-22/h1-10,13,15H,11-12,14H2,(H2,25,29)(H,28,31) LACQOZQIBKGKTF-UHFFFAOYSA-N 463401 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[4-(pyrimidin-2-yl)phenyl]methyl}pyrazole-4-::US10781181, Example 79 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463401&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017328 441573247 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956935 Nc1nn(Cc2nc(no2)-c2ccccc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C21H19ClN6O3/c22-15-7-4-8-16(11-15)30-10-9-24-21(29)17-12-28(26-19(17)23)13-18-25-20(27-31-18)14-5-2-1-3-6-14/h1-8,11-12H,9-10,13H2,(H2,23,26)(H,24,29) XOOYNSPFSZXEDK-UHFFFAOYSA-N 463402 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(3-phenyl-1,2,4-oxadiazol-5-::US10781181, Example 80 Plasma kallikrein Human 6330 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463402&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364575 441573248 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956936 Nc1nn(Cc2nc(no2)-c2ccccc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C21H19ClN6O3/c22-15-7-4-8-16(11-15)30-10-9-24-21(29)17-12-28(26-19(17)23)13-18-25-20(27-31-18)14-5-2-1-3-6-14/h1-8,11-12H,9-10,13H2,(H2,23,26)(H,24,29) XOOYNSPFSZXEDK-UHFFFAOYSA-N 463402 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(3-phenyl-1,2,4-oxadiazol-5-::US10781181, Example 80 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463402&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364575 441573248 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956937 Nc1nn(Cc2cccc(Cl)n2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C18H17Cl2N5O2/c19-12-3-1-5-14(9-12)27-8-7-22-18(26)15-11-25(24-17(15)21)10-13-4-2-6-16(20)23-13/h1-6,9,11H,7-8,10H2,(H2,21,24)(H,22,26) RVAUJIMGDCLMMS-UHFFFAOYSA-N 463403 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-chloropyridin-2-yl)methyl]pyrazole-4-::US10781181, Example 81 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463403&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017341 441573249 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956938 Nc1nn(Cc2cccc(Cl)n2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C18H17Cl2N5O2/c19-12-3-1-5-14(9-12)27-8-7-22-18(26)15-11-25(24-17(15)21)10-13-4-2-6-16(20)23-13/h1-6,9,11H,7-8,10H2,(H2,21,24)(H,22,26) RVAUJIMGDCLMMS-UHFFFAOYSA-N 463403 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(6-chloropyridin-2-yl)methyl]pyrazole-4-::US10781181, Example 81 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463403&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017341 441573249 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956939 CN(Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1)C(C)=O InChI=1S/C23H26ClN5O3/c1-16(30)28(2)13-17-6-8-18(9-7-17)14-29-15-21(22(25)27-29)23(31)26-10-11-32-20-5-3-4-19(24)12-20/h3-9,12,15H,10-11,13-14H2,1-2H3,(H2,25,27)(H,26,31) HEHWDOYRLZHDLS-UHFFFAOYSA-N 463404 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(N-::US10781181, Example 82 Plasma kallikrein Human 710 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463404&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017363 441573250 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956940 CN(Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1)C(C)=O InChI=1S/C23H26ClN5O3/c1-16(30)28(2)13-17-6-8-18(9-7-17)14-29-15-21(22(25)27-29)23(31)26-10-11-32-20-5-3-4-19(24)12-20/h3-9,12,15H,10-11,13-14H2,1-2H3,(H2,25,27)(H,26,31) HEHWDOYRLZHDLS-UHFFFAOYSA-N 463404 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(N-::US10781181, Example 82 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463404&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017363 441573250 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956941 CN(C)C(=O)N(C)Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C24H29ClN6O3/c1-29(2)24(33)30(3)14-17-7-9-18(10-8-17)15-31-16-21(22(26)28-31)23(32)27-11-12-34-20-6-4-5-19(25)13-20/h4-10,13,16H,11-12,14-15H2,1-3H3,(H2,26,28)(H,27,32) VOZTXJYHALVILY-UHFFFAOYSA-N 463405 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-::US10781181, Example 83 Plasma kallikrein Human 298 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463405&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017346 441573251 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956942 CN(C)C(=O)N(C)Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C24H29ClN6O3/c1-29(2)24(33)30(3)14-17-7-9-18(10-8-17)15-31-16-21(22(26)28-31)23(32)27-11-12-34-20-6-4-5-19(25)13-20/h4-10,13,16H,11-12,14-15H2,1-3H3,(H2,26,28)(H,27,32) VOZTXJYHALVILY-UHFFFAOYSA-N 463405 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-::US10781181, Example 83 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463405&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017346 441573251 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956943 CC(C)C(=O)N(C)Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C25H30ClN5O3/c1-17(2)25(33)30(3)14-18-7-9-19(10-8-18)15-31-16-22(23(27)29-31)24(32)28-11-12-34-21-6-4-5-20(26)13-21/h4-10,13,16-17H,11-12,14-15H2,1-3H3,(H2,27,29)(H,28,32) GMSLMJGHQLOFIR-UHFFFAOYSA-N 463406 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(N,2-::US10781181, Example 84 Plasma kallikrein Human 731 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463406&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017343 441573252 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956944 CC(C)C(=O)N(C)Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1 InChI=1S/C25H30ClN5O3/c1-17(2)25(33)30(3)14-18-7-9-19(10-8-18)15-31-16-22(23(27)29-31)24(32)28-11-12-34-21-6-4-5-20(26)13-21/h4-10,13,16-17H,11-12,14-15H2,1-3H3,(H2,27,29)(H,28,32) GMSLMJGHQLOFIR-UHFFFAOYSA-N 463406 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(N,2-::US10781181, Example 84 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463406&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017343 441573252 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956945 Cc1cccn(Cc2ccc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)cc2)c1=O InChI=1S/C26H26ClN5O3/c1-18-4-3-12-31(26(18)34)15-19-7-9-20(10-8-19)16-32-17-23(24(28)30-32)25(33)29-11-13-35-22-6-2-5-21(27)14-22/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,33) LXROWPJGZHKOKV-UHFFFAOYSA-N 463407 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(3-methyl-2-oxopyridin-1-::US10781181, Example 85 Plasma kallikrein Human 3.50 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463407&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364611 441573253 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956946 Cc1cccn(Cc2ccc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)cc2)c1=O InChI=1S/C26H26ClN5O3/c1-18-4-3-12-31(26(18)34)15-19-7-9-20(10-8-19)16-32-17-23(24(28)30-32)25(33)29-11-13-35-22-6-2-5-21(27)14-22/h2-10,12,14,17H,11,13,15-16H2,1H3,(H2,28,30)(H,29,33) LXROWPJGZHKOKV-UHFFFAOYSA-N 463407 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(3-methyl-2-oxopyridin-1-::US10781181, Example 85 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463407&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364611 441573253 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956947 Nc1nn(Cc2ccc(Cn3cccnc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-19-3-1-4-20(13-19)34-12-10-27-23(32)21-16-31(29-22(21)26)15-18-7-5-17(6-8-18)14-30-11-2-9-28-24(30)33/h1-9,11,13,16H,10,12,14-15H2,(H2,26,29)(H,27,32) STLHBGIIMSIYDN-UHFFFAOYSA-N 463408 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyrimidin-1-::US10781181, Example 86 Plasma kallikrein Human 30.2 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463408&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017322 441573254 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956948 Nc1nn(Cc2ccc(Cn3cccnc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-19-3-1-4-20(13-19)34-12-10-27-23(32)21-16-31(29-22(21)26)15-18-7-5-17(6-8-18)14-30-11-2-9-28-24(30)33/h1-9,11,13,16H,10,12,14-15H2,(H2,26,29)(H,27,32) STLHBGIIMSIYDN-UHFFFAOYSA-N 463408 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyrimidin-1-::US10781181, Example 86 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463408&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017322 441573254 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956949 CN(Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1)c1ccccn1 InChI=1S/C26H27ClN6O2/c1-32(24-7-2-3-12-29-24)16-19-8-10-20(11-9-19)17-33-18-23(25(28)31-33)26(34)30-13-14-35-22-6-4-5-21(27)15-22/h2-12,15,18H,13-14,16-17H2,1H3,(H2,28,31)(H,30,34) DZOWXBNYWKUPJY-UHFFFAOYSA-N 463409 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-{[methyl(pyridin-2-::US10781181, Example 87 Plasma kallikrein Human 780 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463409&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364671 441573255 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956950 CN(Cc1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cc1)c1ccccn1 InChI=1S/C26H27ClN6O2/c1-32(24-7-2-3-12-29-24)16-19-8-10-20(11-9-19)17-33-18-23(25(28)31-33)26(34)30-13-14-35-22-6-4-5-21(27)15-22/h2-12,15,18H,13-14,16-17H2,1H3,(H2,28,31)(H,30,34) DZOWXBNYWKUPJY-UHFFFAOYSA-N 463409 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(4-{[methyl(pyridin-2-::US10781181, Example 87 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463409&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364671 441573255 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956951 Nc1nn(Cc2ccc(nc2)-n2cccn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C21H20ClN7O2/c22-16-3-1-4-17(11-16)31-10-8-24-21(30)18-14-28(27-20(18)23)13-15-5-6-19(25-12-15)29-9-2-7-26-29/h1-7,9,11-12,14H,8,10,13H2,(H2,23,27)(H,24,30) JNIAQDLOTWTIRG-UHFFFAOYSA-N 463410 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrazol-1-yl)pyridin-3-yl]methyl}pyrazole-::US10781181, Example 88 Plasma kallikrein Human 9180 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463410&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364568 441573256 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956952 Nc1nn(Cc2ccc(nc2)-n2cccn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C21H20ClN7O2/c22-16-3-1-4-17(11-16)31-10-8-24-21(30)18-14-28(27-20(18)23)13-15-5-6-19(25-12-15)29-9-2-7-26-29/h1-7,9,11-12,14H,8,10,13H2,(H2,23,27)(H,24,30) JNIAQDLOTWTIRG-UHFFFAOYSA-N 463410 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrazol-1-yl)pyridin-3-yl]methyl}pyrazole-::US10781181, Example 88 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463410&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364568 441573256 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956953 Cc1cnn(c1)-c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cn1 InChI=1S/C22H22ClN7O2/c1-15-10-27-30(12-15)20-6-5-16(11-26-20)13-29-14-19(21(24)28-29)22(31)25-7-8-32-18-4-2-3-17(23)9-18/h2-6,9-12,14H,7-8,13H2,1H3,(H2,24,28)(H,25,31) KGECLGJANPHWDS-UHFFFAOYSA-N 463411 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(4-methylpyrazol-1-yl)pyridin-3-::US10781181, Example 89 Plasma kallikrein Human 3350 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463411&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364666 441573257 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956954 Cc1cnn(c1)-c1ccc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)cn1 InChI=1S/C22H22ClN7O2/c1-15-10-27-30(12-15)20-6-5-16(11-26-20)13-29-14-19(21(24)28-29)22(31)25-7-8-32-18-4-2-3-17(23)9-18/h2-6,9-12,14H,7-8,13H2,1H3,(H2,24,28)(H,25,31) KGECLGJANPHWDS-UHFFFAOYSA-N 463411 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(4-methylpyrazol-1-yl)pyridin-3-::US10781181, Example 89 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463411&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364666 441573257 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956955 Nc1nn(Cc2nc(Cc3ccccc3)no2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H21ClN6O3/c23-16-7-4-8-17(12-16)31-10-9-25-22(30)18-13-29(27-21(18)24)14-20-26-19(28-32-20)11-15-5-2-1-3-6-15/h1-8,12-13H,9-11,14H2,(H2,24,27)(H,25,30) ZAVHRTIPTBDHGV-UHFFFAOYSA-N 463412 3-amino-1-[(3-benzyl-1,2,4-oxadiazol-5-yl)methyl]-N-[2-(3-::US10781181, Example 90 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463412&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364622 441573258 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956956 Nc1nn(Cc2nc(Cc3ccccc3)no2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H21ClN6O3/c23-16-7-4-8-17(12-16)31-10-9-25-22(30)18-13-29(27-21(18)24)14-20-26-19(28-32-20)11-15-5-2-1-3-6-15/h1-8,12-13H,9-11,14H2,(H2,24,27)(H,25,30) ZAVHRTIPTBDHGV-UHFFFAOYSA-N 463412 3-amino-1-[(3-benzyl-1,2,4-oxadiazol-5-yl)methyl]-N-[2-(3-::US10781181, Example 90 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463412&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364622 441573258 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956957 Nc1nn(Cc2ccnc(c2)-c2cccnc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H21ClN6O2/c24-18-4-1-5-19(12-18)32-10-9-28-23(31)20-15-30(29-22(20)25)14-16-6-8-27-21(11-16)17-3-2-7-26-13-17/h1-8,11-13,15H,9-10,14H2,(H2,25,29)(H,28,31) OJHPZGRDTHCYQP-UHFFFAOYSA-N 463413 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyridin-3-yl)pyridin-4-yl]methyl}pyrazole-::US10781181, Example 91 Plasma kallikrein Human 3780 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463413&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017325 441573259 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956958 Nc1nn(Cc2ccnc(c2)-c2cccnc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H21ClN6O2/c24-18-4-1-5-19(12-18)32-10-9-28-23(31)20-15-30(29-22(20)25)14-16-6-8-27-21(11-16)17-3-2-7-26-13-17/h1-8,11-13,15H,9-10,14H2,(H2,25,29)(H,28,31) OJHPZGRDTHCYQP-UHFFFAOYSA-N 463413 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(pyridin-3-yl)pyridin-4-yl]methyl}pyrazole-::US10781181, Example 91 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463413&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017325 441573259 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956959 Nc1nn(Cc2ccc3[nH]ncc3c2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN6O2/c21-15-2-1-3-16(9-15)29-7-6-23-20(28)17-12-27(26-19(17)22)11-13-4-5-18-14(8-13)10-24-25-18/h1-5,8-10,12H,6-7,11H2,(H2,22,26)(H,23,28)(H,24,25) FXFRSODTSSHENF-UHFFFAOYSA-N 463415 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-(1H-indazol-5-ylmethyl)pyrazole-4-::US10781181, Example 92 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463415&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364689 441573261 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956960 Nc1nn(Cc2ccc3[nH]ncc3c2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C20H19ClN6O2/c21-15-2-1-3-16(9-15)29-7-6-23-20(28)17-12-27(26-19(17)22)11-13-4-5-18-14(8-13)10-24-25-18/h1-5,8-10,12H,6-7,11H2,(H2,22,26)(H,23,28)(H,24,25) FXFRSODTSSHENF-UHFFFAOYSA-N 463415 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-(1H-indazol-5-ylmethyl)pyrazole-4-::US10781181, Example 92 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463415&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364689 441573261 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956961 Cn1ncc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc12 InChI=1S/C21H21ClN6O2/c1-27-19-6-5-14(9-15(19)11-25-27)12-28-13-18(20(23)26-28)21(29)24-7-8-30-17-4-2-3-16(22)10-17/h2-6,9-11,13H,7-8,12H2,1H3,(H2,23,26)(H,24,29) KWVPJVDKNQQKNI-UHFFFAOYSA-N 463416 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(1-methylindazol-5-yl)methyl]pyrazole-4-::US10781181, Example 93 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463416&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017362 441573262 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956962 Cn1ncc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc12 InChI=1S/C21H21ClN6O2/c1-27-19-6-5-14(9-15(19)11-25-27)12-28-13-18(20(23)26-28)21(29)24-7-8-30-17-4-2-3-16(22)10-17/h2-6,9-11,13H,7-8,12H2,1H3,(H2,23,26)(H,24,29) KWVPJVDKNQQKNI-UHFFFAOYSA-N 463416 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(1-methylindazol-5-yl)methyl]pyrazole-4-::US10781181, Example 93 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463416&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017362 441573262 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956963 Nc1nn(Cc2ccnc(c2)N2CCCC2=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H23ClN6O3/c23-16-3-1-4-17(12-16)32-10-8-26-22(31)18-14-28(27-21(18)24)13-15-6-7-25-19(11-15)29-9-2-5-20(29)30/h1,3-4,6-7,11-12,14H,2,5,8-10,13H2,(H2,24,27)(H,26,31) SSVAZIQXGGSLQR-UHFFFAOYSA-N 463417 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-::US10781181, Example 94 Plasma kallikrein Human 3140 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463417&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364585 441573263 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956964 Nc1nn(Cc2ccnc(c2)N2CCCC2=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H23ClN6O3/c23-16-3-1-4-17(12-16)32-10-8-26-22(31)18-14-28(27-21(18)24)13-15-6-7-25-19(11-15)29-9-2-5-20(29)30/h1,3-4,6-7,11-12,14H,2,5,8-10,13H2,(H2,24,27)(H,26,31) SSVAZIQXGGSLQR-UHFFFAOYSA-N 463417 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-::US10781181, Example 94 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463417&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364585 441573263 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956965 Cc1nc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc2n1C InChI=1S/C22H23ClN6O2/c1-14-26-19-10-15(6-7-20(19)28(14)2)12-29-13-18(21(24)27-29)22(30)25-8-9-31-17-5-3-4-16(23)11-17/h3-7,10-11,13H,8-9,12H2,1-2H3,(H2,24,27)(H,25,30) VDZWAOLYAZSWEL-UHFFFAOYSA-N 463418 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(1,2-dimethyl-1,3-benzodiazol-5-::US10781181, Example 95 Plasma kallikrein Human 1900 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463418&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364659 441573264 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956966 Cc1nc2cc(Cn3cc(C(=O)NCCOc4cccc(Cl)c4)c(N)n3)ccc2n1C InChI=1S/C22H23ClN6O2/c1-14-26-19-10-15(6-7-20(19)28(14)2)12-29-13-18(21(24)27-29)22(30)25-8-9-31-17-5-3-4-16(23)11-17/h3-7,10-11,13H,8-9,12H2,1-2H3,(H2,24,27)(H,25,30) VDZWAOLYAZSWEL-UHFFFAOYSA-N 463418 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-[(1,2-dimethyl-1,3-benzodiazol-5-::US10781181, Example 95 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463418&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364659 441573264 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956967 Nc1nn(Cc2ccc(nc2)N2CCCC2=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H23ClN6O3/c23-16-3-1-4-17(11-16)32-10-8-25-22(31)18-14-28(27-21(18)24)13-15-6-7-19(26-12-15)29-9-2-5-20(29)30/h1,3-4,6-7,11-12,14H,2,5,8-10,13H2,(H2,24,27)(H,25,31) GQBOCGWOKDHASZ-UHFFFAOYSA-N 463419 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-::US10781181, Example 96 Plasma kallikrein Human 2230 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463419&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364662 441573265 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956968 Nc1nn(Cc2ccc(nc2)N2CCCC2=O)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C22H23ClN6O3/c23-16-3-1-4-17(11-16)32-10-8-25-22(31)18-14-28(27-21(18)24)13-15-6-7-19(26-12-15)29-9-2-5-20(29)30/h1,3-4,6-7,11-12,14H,2,5,8-10,13H2,(H2,24,27)(H,25,31) GQBOCGWOKDHASZ-UHFFFAOYSA-N 463419 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-::US10781181, Example 96 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463419&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364662 441573265 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956969 Nc1nn(Cc2ccc(nc2)-c2cccnc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H21ClN6O2/c24-18-4-1-5-19(11-18)32-10-9-27-23(31)20-15-30(29-22(20)25)14-16-6-7-21(28-12-16)17-3-2-8-26-13-17/h1-8,11-13,15H,9-10,14H2,(H2,25,29)(H,27,31) KKVLDHSBIGIPMZ-UHFFFAOYSA-N 463420 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyridin-3-yl)pyridin-3-yl]methyl}pyrazole-::US10781181, Example 97 Plasma kallikrein Human 1130 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463420&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017357 441573266 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956970 Nc1nn(Cc2ccc(nc2)-c2cccnc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H21ClN6O2/c24-18-4-1-5-19(11-18)32-10-9-27-23(31)20-15-30(29-22(20)25)14-16-6-7-21(28-12-16)17-3-2-8-26-13-17/h1-8,11-13,15H,9-10,14H2,(H2,25,29)(H,27,31) KKVLDHSBIGIPMZ-UHFFFAOYSA-N 463420 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyridin-3-yl)pyridin-3-yl]methyl}pyrazole-::US10781181, Example 97 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463420&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017357 441573266 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956971 COc1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccc1Cn1ccccc1=O InChI=1S/C26H26ClN5O4/c1-35-23-13-18(8-9-19(23)16-31-11-3-2-7-24(31)33)15-32-17-22(25(28)30-32)26(34)29-10-12-36-21-6-4-5-20(27)14-21/h2-9,11,13-14,17H,10,12,15-16H2,1H3,(H2,28,30)(H,29,34) YPTWWJVNXVZQJM-UHFFFAOYSA-N 463421 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({3-methoxy-4-[(2-oxopyridin-1-::US10781181, Example 98 Plasma kallikrein Human 9.40 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463421&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364696 441573267 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956972 COc1cc(Cn2cc(C(=O)NCCOc3cccc(Cl)c3)c(N)n2)ccc1Cn1ccccc1=O InChI=1S/C26H26ClN5O4/c1-35-23-13-18(8-9-19(23)16-31-11-3-2-7-24(31)33)15-32-17-22(25(28)30-32)26(34)29-10-12-36-21-6-4-5-20(27)14-21/h2-9,11,13-14,17H,10,12,15-16H2,1H3,(H2,28,30)(H,29,34) YPTWWJVNXVZQJM-UHFFFAOYSA-N 463421 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({3-methoxy-4-[(2-oxopyridin-1-::US10781181, Example 98 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463421&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364696 441573267 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956973 Nc1nn(Cc2ccc(Cn3c(F)cccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClFN5O3/c26-19-3-1-4-20(13-19)35-12-11-29-25(34)21-16-31(30-24(21)28)14-17-7-9-18(10-8-17)15-32-22(27)5-2-6-23(32)33/h1-10,13,16H,11-12,14-15H2,(H2,28,30)(H,29,34) HYYVIMQLEHYSJS-UHFFFAOYSA-N 463422 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-fluoro-6-oxopyridin-1-::US10781181, Example 99 Plasma kallikrein Human 2070 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463422&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017331 441573268 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956974 Nc1nn(Cc2ccc(Cn3c(F)cccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClFN5O3/c26-19-3-1-4-20(13-19)35-12-11-29-25(34)21-16-31(30-24(21)28)14-17-7-9-18(10-8-17)15-32-22(27)5-2-6-23(32)33/h1-10,13,16H,11-12,14-15H2,(H2,28,30)(H,29,34) HYYVIMQLEHYSJS-UHFFFAOYSA-N 463422 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-fluoro-6-oxopyridin-1-::US10781181, Example 99 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463422&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017331 441573268 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956975 Nc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClFN5O3/c26-19-2-1-3-21(12-19)35-11-10-29-25(34)22-16-32(30-24(22)28)14-18-6-4-17(5-7-18)13-31-15-20(27)8-9-23(31)33/h1-9,12,15-16H,10-11,13-14H2,(H2,28,30)(H,29,34) KZWKGQOVLZMLEU-UHFFFAOYSA-N 463423 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(5-fluoro-2-oxopyridin-1-::US10781181, Example 100 Plasma kallikrein Human 6.20 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463423&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364592 441573269 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956976 Nc1nn(Cc2ccc(Cn3cc(F)ccc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClFN5O3/c26-19-2-1-3-21(12-19)35-11-10-29-25(34)22-16-32(30-24(22)28)14-18-6-4-17(5-7-18)13-31-15-20(27)8-9-23(31)33/h1-9,12,15-16H,10-11,13-14H2,(H2,28,30)(H,29,34) KZWKGQOVLZMLEU-UHFFFAOYSA-N 463423 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(5-fluoro-2-oxopyridin-1-::US10781181, Example 100 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463423&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364592 441573269 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956977 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2F)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClFN5O3/c26-19-4-3-5-20(13-19)35-11-9-29-25(34)21-16-32(30-24(21)28)15-18-8-7-17(12-22(18)27)14-31-10-2-1-6-23(31)33/h1-8,10,12-13,16H,9,11,14-15H2,(H2,28,30)(H,29,34) FWNOWWIMXHWURN-UHFFFAOYSA-N 463424 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({2-fluoro-4-[(2-oxopyridin-1-::US10781181, Example 101 Plasma kallikrein Human 7.60 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463424&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364669 441573270 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956978 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2F)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C25H23ClFN5O3/c26-19-4-3-5-20(13-19)35-11-9-29-25(34)21-16-32(30-24(21)28)15-18-8-7-17(12-22(18)27)14-31-10-2-1-6-23(31)33/h1-8,10,12-13,16H,9,11,14-15H2,(H2,28,30)(H,29,34) FWNOWWIMXHWURN-UHFFFAOYSA-N 463424 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({2-fluoro-4-[(2-oxopyridin-1-::US10781181, Example 101 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463424&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364669 441573270 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956979 Nc1nn(Cc2ccc(Cn3ccccc3=O)cn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-18-4-3-5-20(12-18)34-11-9-27-24(33)21-16-31(29-23(21)26)15-19-8-7-17(13-28-19)14-30-10-2-1-6-22(30)32/h1-8,10,12-13,16H,9,11,14-15H2,(H2,26,29)(H,27,33) CPRWTCGSTDZPML-UHFFFAOYSA-N 463425 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({5-[(2-oxopyridin-1-yl)methyl]pyridin-2-::US10781181, Example 102 Plasma kallikrein Human 72.1 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463425&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364639 441573271 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956980 Nc1nn(Cc2ccc(Cn3ccccc3=O)cn2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C24H23ClN6O3/c25-18-4-3-5-20(12-18)34-11-9-27-24(33)21-16-31(29-23(21)26)15-19-8-7-17(13-28-19)14-30-10-2-1-6-22(30)32/h1-8,10,12-13,16H,9,11,14-15H2,(H2,26,29)(H,27,33) CPRWTCGSTDZPML-UHFFFAOYSA-N 463425 3-amino-N-[2-(3-chlorophenoxy)ethyl]-1-({5-[(2-oxopyridin-1-yl)methyl]pyridin-2-::US10781181, Example 102 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463425&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364639 441573271 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956981 FC(F)(F)c1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H23ClF3N5O2/c24-17-4-3-5-18(12-17)34-11-8-28-22(33)19-15-32(30-21(19)23(25,26)27)14-16-6-7-20(29-13-16)31-9-1-2-10-31/h3-7,12-13,15H,1-2,8-11,14H2,(H,28,33) WWEYVYYGKVXIBW-UHFFFAOYSA-N 463426 N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3-::US10781181, Example 28 Plasma kallikrein Human 2390 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463426&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017340 441573272 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956982 FC(F)(F)c1nn(Cc2ccc(nc2)N2CCCC2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C23H23ClF3N5O2/c24-17-4-3-5-18(12-17)34-11-8-28-22(33)19-15-32(30-21(19)23(25,26)27)14-16-6-7-20(29-13-16)31-9-1-2-10-31/h3-7,12-13,15H,1-2,8-11,14H2,(H,28,33) WWEYVYYGKVXIBW-UHFFFAOYSA-N 463426 N-[2-(3-chlorophenoxy)ethyl]-1-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}-3-::US10781181, Example 28 Kallikrein-1 Human >10000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463426&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017340 441573272 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956983 Cc1nn(Cc2ccc(Cn3ccccc3=O)cc2)c(C)c1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C27H27ClN4O3/c1-19-26(27(34)29-13-15-35-24-7-5-6-23(28)16-24)20(2)32(30-19)18-22-11-9-21(10-12-22)17-31-14-4-3-8-25(31)33/h3-12,14,16H,13,15,17-18H2,1-2H3,(H,29,34) SBEUCDJMURUTNS-UHFFFAOYSA-N 463427 N-[2-(3-chlorophenoxy)ethyl]-3,5-dimethyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 103 Plasma kallikrein Human >10000 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463427&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364629 441573273 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956984 Cc1nn(Cc2ccc(Cn3ccccc3=O)cc2)c(C)c1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C27H27ClN4O3/c1-19-26(27(34)29-13-15-35-24-7-5-6-23(28)16-24)20(2)32(30-19)18-22-11-9-21(10-12-22)17-31-14-4-3-8-25(31)33/h3-12,14,16H,13,15,17-18H2,1-2H3,(H,29,34) SBEUCDJMURUTNS-UHFFFAOYSA-N 463427 N-[2-(3-chlorophenoxy)ethyl]-3,5-dimethyl-1-({4-[(2-oxopyridin-1-::US10781181, Example 103 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463427&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364629 441573273 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956985 COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C28H29ClN4O4/c1-20-10-12-32(27(34)14-20)16-21-6-8-22(9-7-21)17-33-18-25(26(31-33)19-36-2)28(35)30-11-13-37-24-5-3-4-23(29)15-24/h3-10,12,14-15,18H,11,13,16-17,19H2,1-2H3,(H,30,35) FTMLEBBQRKVAFL-UHFFFAOYSA-N 463428 N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2-oxopyridin-1-::US10781181, Example 104 Plasma kallikrein Human 413 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463428&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364691 441573274 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956986 COCc1nn(Cc2ccc(Cn3ccc(C)cc3=O)cc2)cc1C(=O)NCCOc1cccc(Cl)c1 InChI=1S/C28H29ClN4O4/c1-20-10-12-32(27(34)14-20)16-21-6-8-22(9-7-21)17-33-18-25(26(31-33)19-36-2)28(35)30-11-13-37-24-5-3-4-23(29)15-24/h3-10,12,14-15,18H,11,13,16-17,19H2,1-2H3,(H,30,35) FTMLEBBQRKVAFL-UHFFFAOYSA-N 463428 N-[2-(3-chlorophenoxy)ethyl]-3-(methoxymethyl)-1-({4-[(4-methyl-2-oxopyridin-1-::US10781181, Example 104 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463428&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364691 441573274 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956987 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m0/s1 QZVBCPBEJSYHNK-QFIPXVFZSA-N 463429 3-amino-N-[(3S)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 105 Plasma kallikrein Human 3.80 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463429&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364650 441573275 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956988 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m0/s1 QZVBCPBEJSYHNK-QFIPXVFZSA-N 463429 3-amino-N-[(3S)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 105 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463429&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364650 441573275 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956989 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m1/s1 QZVBCPBEJSYHNK-JOCHJYFZSA-N 463430 3-amino-N-[(3R)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 106 Plasma kallikrein Human 684 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463430&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364678 441573276 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956990 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O2/c28-21-4-3-5-23(14-21)32-13-11-22(17-32)30-27(36)24-18-34(31-26(24)29)16-20-9-7-19(8-10-20)15-33-12-2-1-6-25(33)35/h1-10,12,14,18,22H,11,13,15-17H2,(H2,29,31)(H,30,36)/t22-/m1/s1 QZVBCPBEJSYHNK-JOCHJYFZSA-N 463430 3-amino-N-[(3R)-1-(3-chlorophenyl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 106 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463430&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364678 441573276 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956991 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1=O)c1cccc(Cl)c1 InChI=1S/C27H25ClN6O3/c28-20-4-3-5-21(14-20)34-13-11-23(27(34)37)30-26(36)22-17-33(31-25(22)29)16-19-9-7-18(8-10-19)15-32-12-2-1-6-24(32)35/h1-10,12,14,17,23H,11,13,15-16H2,(H2,29,31)(H,30,36)/t23-/m0/s1 PLRXGUSRGDVYFS-QHCPKHFHSA-N 463431 3-amino-N-[(3S)-1-(3-chlorophenyl)-2-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 107 Plasma kallikrein Human 4.80 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463431&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364607 441573277 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956992 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1=O)c1cccc(Cl)c1 InChI=1S/C27H25ClN6O3/c28-20-4-3-5-21(14-20)34-13-11-23(27(34)37)30-26(36)22-17-33(31-25(22)29)16-19-9-7-18(8-10-19)15-32-12-2-1-6-24(32)35/h1-10,12,14,17,23H,11,13,15-16H2,(H2,29,31)(H,30,36)/t23-/m0/s1 PLRXGUSRGDVYFS-QHCPKHFHSA-N 463431 3-amino-N-[(3S)-1-(3-chlorophenyl)-2-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 107 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463431&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364607 441573277 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956993 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(Cc2cccc(Cl)c2)C1 InChI=1S/C28H29ClN6O2/c29-23-5-3-4-22(14-23)15-33-13-11-24(18-33)31-28(37)25-19-35(32-27(25)30)17-21-9-7-20(8-10-21)16-34-12-2-1-6-26(34)36/h1-10,12,14,19,24H,11,13,15-18H2,(H2,30,32)(H,31,37)/t24-/m1/s1 AZEWSURGSXDQEJ-XMMPIXPASA-N 463432 3-amino-N-[(3R)-1-[(3-chlorophenyl)methyl]pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 108 Plasma kallikrein Human 299 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463432&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364643 441573278 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956994 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(Cc2cccc(Cl)c2)C1 InChI=1S/C28H29ClN6O2/c29-23-5-3-4-22(14-23)15-33-13-11-24(18-33)31-28(37)25-19-35(32-27(25)30)17-21-9-7-20(8-10-21)16-34-12-2-1-6-26(34)36/h1-10,12,14,19,24H,11,13,15-18H2,(H2,30,32)(H,31,37)/t24-/m1/s1 AZEWSURGSXDQEJ-XMMPIXPASA-N 463432 3-amino-N-[(3R)-1-[(3-chlorophenyl)methyl]pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 108 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463432&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364643 441573278 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956995 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(Cc2cccc(Cl)c2)C1 InChI=1S/C28H29ClN6O2/c29-23-5-3-4-22(14-23)15-33-13-11-24(18-33)31-28(37)25-19-35(32-27(25)30)17-21-9-7-20(8-10-21)16-34-12-2-1-6-26(34)36/h1-10,12,14,19,24H,11,13,15-18H2,(H2,30,32)(H,31,37)/t24-/m0/s1 AZEWSURGSXDQEJ-DEOSSOPVSA-N 463433 3-amino-N-[(3S)-1-[(3-chlorophenyl)methyl]pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 109 Plasma kallikrein Human 384 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463433&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364633 441573279 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956996 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(Cc2cccc(Cl)c2)C1 InChI=1S/C28H29ClN6O2/c29-23-5-3-4-22(14-23)15-33-13-11-24(18-33)31-28(37)25-19-35(32-27(25)30)17-21-9-7-20(8-10-21)16-34-12-2-1-6-26(34)36/h1-10,12,14,19,24H,11,13,15-18H2,(H2,30,32)(H,31,37)/t24-/m0/s1 AZEWSURGSXDQEJ-DEOSSOPVSA-N 463433 3-amino-N-[(3S)-1-[(3-chlorophenyl)methyl]pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 109 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463433&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364633 441573279 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956997 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1=O)c1cccc(Cl)c1 InChI=1S/C27H25ClN6O3/c28-20-4-3-5-21(14-20)34-13-11-23(27(34)37)30-26(36)22-17-33(31-25(22)29)16-19-9-7-18(8-10-19)15-32-12-2-1-6-24(32)35/h1-10,12,14,17,23H,11,13,15-16H2,(H2,29,31)(H,30,36)/t23-/m1/s1 PLRXGUSRGDVYFS-HSZRJFAPSA-N 463434 3-amino-N-[(3R)-1-(3-chlorophenyl)-2-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 110 Plasma kallikrein Human 4.00 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463434&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364595 441573280 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 956998 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CCN(C1=O)c1cccc(Cl)c1 InChI=1S/C27H25ClN6O3/c28-20-4-3-5-21(14-20)34-13-11-23(27(34)37)30-26(36)22-17-33(31-25(22)29)16-19-9-7-18(8-10-19)15-32-12-2-1-6-24(32)35/h1-10,12,14,17,23H,11,13,15-16H2,(H2,29,31)(H,30,36)/t23-/m1/s1 PLRXGUSRGDVYFS-HSZRJFAPSA-N 463434 3-amino-N-[(3R)-1-(3-chlorophenyl)-2-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 110 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463434&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364595 441573280 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 956999 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CN(C(=O)C1)c1cccc(Cl)c1 InChI=1S/C27H25ClN6O3/c28-20-4-3-5-22(12-20)34-16-21(13-25(34)36)30-27(37)23-17-33(31-26(23)29)15-19-9-7-18(8-10-19)14-32-11-2-1-6-24(32)35/h1-12,17,21H,13-16H2,(H2,29,31)(H,30,37)/t21-/m0/s1 VTHWJDWMGGWGJR-NRFANRHFSA-N 463435 3-amino-N-[(3S)-1-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 111 Plasma kallikrein Human 42.1 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463435&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364652 441573281 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957000 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@@H]1CN(C(=O)C1)c1cccc(Cl)c1 InChI=1S/C27H25ClN6O3/c28-20-4-3-5-22(12-20)34-16-21(13-25(34)36)30-27(37)23-17-33(31-26(23)29)15-19-9-7-18(8-10-19)14-32-11-2-1-6-24(32)35/h1-12,17,21H,13-16H2,(H2,29,31)(H,30,37)/t21-/m0/s1 VTHWJDWMGGWGJR-NRFANRHFSA-N 463435 3-amino-N-[(3S)-1-(3-chlorophenyl)-5-oxopyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 111 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463435&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364652 441573281 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 957001 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cc(Cl)ccn1 InChI=1S/C26H26ClN7O2/c27-20-8-10-29-23(13-20)32-12-9-21(16-32)30-26(36)22-17-34(31-25(22)28)15-19-6-4-18(5-7-19)14-33-11-2-1-3-24(33)35/h1-8,10-11,13,17,21H,9,12,14-16H2,(H2,28,31)(H,30,36)/t21-/m0/s1 HUUKZGJXVSYRHQ-NRFANRHFSA-N 463436 3-amino-N-[(3S)-1-(4-chloropyridin-2-yl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 112 Plasma kallikrein Human 7460 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463436&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364552 441573282 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957002 Nc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)N[C@H]1CCN(C1)c1cc(Cl)ccn1 InChI=1S/C26H26ClN7O2/c27-20-8-10-29-23(13-20)32-12-9-21(16-32)30-26(36)22-17-34(31-25(22)28)15-19-6-4-18(5-7-19)14-33-11-2-1-3-24(33)35/h1-8,10-11,13,17,21H,9,12,14-16H2,(H2,28,31)(H,30,36)/t21-/m0/s1 HUUKZGJXVSYRHQ-NRFANRHFSA-N 463436 3-amino-N-[(3S)-1-(4-chloropyridin-2-yl)pyrrolidin-3-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 112 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463436&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364552 441573282 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 957003 C[C@H](COc1cccc(Cl)c1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N InChI=1S/C26H26ClN5O3/c1-18(17-35-22-6-4-5-21(27)13-22)29-26(34)23-16-32(30-25(23)28)15-20-10-8-19(9-11-20)14-31-12-3-2-7-24(31)33/h2-13,16,18H,14-15,17H2,1H3,(H2,28,30)(H,29,34)/t18-/m1/s1 WWDYKPQPCZPGFF-GOSISDBHSA-N 463437 3-amino-N-[(2R)-1-(3-chlorophenoxy)propan-2-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 113 Plasma kallikrein Human 316 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463437&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 132017366 441573283 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957004 C[C@H](COc1cccc(Cl)c1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N InChI=1S/C26H26ClN5O3/c1-18(17-35-22-6-4-5-21(27)13-22)29-26(34)23-16-32(30-25(23)28)15-20-10-8-19(9-11-20)14-31-12-3-2-7-24(31)33/h2-13,16,18H,14-15,17H2,1H3,(H2,28,30)(H,29,34)/t18-/m1/s1 WWDYKPQPCZPGFF-GOSISDBHSA-N 463437 3-amino-N-[(2R)-1-(3-chlorophenoxy)propan-2-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 113 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463437&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 132017366 441573283 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 957005 C[C@@H](COc1cccc(Cl)c1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N InChI=1S/C26H26ClN5O3/c1-18(17-35-22-6-4-5-21(27)13-22)29-26(34)23-16-32(30-25(23)28)15-20-10-8-19(9-11-20)14-31-12-3-2-7-24(31)33/h2-13,16,18H,14-15,17H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1 WWDYKPQPCZPGFF-SFHVURJKSA-N 463438 3-amino-N-[(2S)-1-(3-chlorophenoxy)propan-2-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 114 Plasma kallikrein Human 140 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463438&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364621 441573284 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957006 C[C@@H](COc1cccc(Cl)c1)NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N InChI=1S/C26H26ClN5O3/c1-18(17-35-22-6-4-5-21(27)13-22)29-26(34)23-16-32(30-25(23)28)15-20-10-8-19(9-11-20)14-31-12-3-2-7-24(31)33/h2-13,16,18H,14-15,17H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1 WWDYKPQPCZPGFF-SFHVURJKSA-N 463438 3-amino-N-[(2S)-1-(3-chlorophenoxy)propan-2-yl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 114 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463438&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364621 441573284 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 957007 C[C@H](NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)C(=O)N(C)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O3/c1-18(27(37)32(2)22-7-5-6-21(28)14-22)30-26(36)23-17-34(31-25(23)29)16-20-11-9-19(10-12-20)15-33-13-4-3-8-24(33)35/h3-14,17-18H,15-16H2,1-2H3,(H2,29,31)(H,30,36)/t18-/m0/s1 VVRWWUMFOFUNPL-SFHVURJKSA-N 463439 (2S)-2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-::US10781181, Example 116 Plasma kallikrein Human 390 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463439&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364681 441573285 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957008 C[C@H](NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)C(=O)N(C)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O3/c1-18(27(37)32(2)22-7-5-6-21(28)14-22)30-26(36)23-17-34(31-25(23)29)16-20-11-9-19(10-12-20)15-33-13-4-3-8-24(33)35/h3-14,17-18H,15-16H2,1-2H3,(H2,29,31)(H,30,36)/t18-/m0/s1 VVRWWUMFOFUNPL-SFHVURJKSA-N 463439 (2S)-2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-::US10781181, Example 116 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463439&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364681 441573285 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 957009 C[C@@H](NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)C(=O)N(C)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O3/c1-18(27(37)32(2)22-7-5-6-21(28)14-22)30-26(36)23-17-34(31-25(23)29)16-20-11-9-19(10-12-20)15-33-13-4-3-8-24(33)35/h3-14,17-18H,15-16H2,1-2H3,(H2,29,31)(H,30,36)/t18-/m1/s1 VVRWWUMFOFUNPL-GOSISDBHSA-N 463440 (2R)-2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-::US10781181, Example 117 Plasma kallikrein Human 3020 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463440&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364867 441573286 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957010 C[C@@H](NC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)C(=O)N(C)c1cccc(Cl)c1 InChI=1S/C27H27ClN6O3/c1-18(27(37)32(2)22-7-5-6-21(28)14-22)30-26(36)23-17-34(31-25(23)29)16-20-11-9-19(10-12-20)15-33-13-4-3-8-24(33)35/h3-14,17-18H,15-16H2,1-2H3,(H2,29,31)(H,30,36)/t18-/m1/s1 VVRWWUMFOFUNPL-GOSISDBHSA-N 463440 (2R)-2-{[3-amino-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazol-4-::US10781181, Example 117 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463440&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364867 441573286 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 957011 C[C@@H](CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)Oc1cccc(Cl)c1 InChI=1S/C26H26ClN5O3/c1-18(35-22-6-4-5-21(27)13-22)14-29-26(34)23-17-32(30-25(23)28)16-20-10-8-19(9-11-20)15-31-12-3-2-7-24(31)33/h2-13,17-18H,14-16H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1 ILFFTOFUUCFIFF-SFHVURJKSA-N 463441 3-amino-N-[(2R/S)-2-(3-chlorophenoxy)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 118 Plasma kallikrein Human 13.3 US Patent 10.7270/Q2P55RK5 aid1804814 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463441&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121364589 441573287 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 957012 C[C@@H](CNC(=O)c1cn(Cc2ccc(Cn3ccccc3=O)cc2)nc1N)Oc1cccc(Cl)c1 InChI=1S/C26H26ClN5O3/c1-18(35-22-6-4-5-21(27)13-22)14-29-26(34)23-17-32(30-25(23)28)16-20-10-8-19(9-11-20)15-31-12-3-2-7-24(31)33/h2-13,17-18H,14-16H2,1H3,(H2,28,30)(H,29,34)/t18-/m0/s1 ILFFTOFUUCFIFF-SFHVURJKSA-N 463441 3-amino-N-[(2R/S)-2-(3-chlorophenoxy)propyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 118 Kallikrein-1 Human >40000 US Patent 10.7270/Q2P55RK5 aid1804815 US10781181 Evans, DM; Davie, RL; Edwards, HJ; Hodgson, ST 9/22/2020 5/3/2021 KALVISTA PHARMACEUTICALS LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=463441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=463441&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121364589 441573287 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1